Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Valvular Heart Disease

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 437 articles:
HTML format



Single Articles


    May 2020
  1. OTERO D, Raza M, Kahlon T, Singh V, et al
    Transcatheter edge-to-edge mitral valve repair for annuloplasty ring dehiscence: The peri-ring approach.
    Catheter Cardiovasc Interv. 2020 May 21. doi: 10.1002/ccd.28952.
    PubMed     Abstract available


  2. SEPPELT PC, Mas-Peiro S, De Rosa R, Murray IM, et al
    Dynamics of cerebral oxygenation during rapid ventricular pacing and its impact on outcome in transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 May 20. doi: 10.1002/ccd.28975.
    PubMed     Abstract available


  3. SAMMOUR Y, Kadri AN, Gajulapalli RD, Kaur M, et al
    Comparison of acute recoil after valve deployment and after post-dilation in patients undergoing transfemoral-transcatheter aortic valve replacement with SAPIEN-3 valve.
    Catheter Cardiovasc Interv. 2020 May 19. doi: 10.1002/ccd.28968.
    PubMed     Abstract available


  4. XIONG TY, Liao YB, Li YJ, Chen F, et al
    Effect of concomitant aortic regurgitation on early hypo-attenuated leaflet thickening after transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis.
    Catheter Cardiovasc Interv. 2020 May 13. doi: 10.1002/ccd.28903.
    PubMed     Abstract available


  5. GORLA R, De Marco F, Garatti A, Bianchi G, et al
    Impact of aortic angle on transcatheter aortic valve implantation outcome with Evolut-R, Portico, and Acurate-NEO.
    Catheter Cardiovasc Interv. 2020 May 13. doi: 10.1002/ccd.28957.
    PubMed     Abstract available


  6. GREENBAUM AB, Khan JM, Rogers T, Babaliaros VC, et al
    First-in-human transcatheter pledget-assisted suture tricuspid annuloplasty for severe tricuspid insufficiency.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28955.
    PubMed     Abstract available


  7. OSMAN M, Khan MZ, Farjo PD, Khan MU, et al
    In-hospital outcomes of percutaneous mitral valve repair in patients with chronic obstructive pulmonary disease: insights from the national inpatient sample database.
    Catheter Cardiovasc Interv. 2020 May 6. doi: 10.1002/ccd.28913.
    PubMed     Abstract available


  8. VEULEMANS V, Maier O, Bosbach G, Polzin A, et al
    Novel insights on outcome in horizontal aorta with self-expandable new-generation transcatheter aortic valve replacement devices.
    Catheter Cardiovasc Interv. 2020 May 6. doi: 10.1002/ccd.28961.
    PubMed     Abstract available


  9. EL-SABAWI B, Guerrero ME, Eleid MF, Rihal CS, et al
    Acute fulminant hemolysis after transcatheter mitral valve replacement for mitral annular calcification.
    Catheter Cardiovasc Interv. 2020 May 6. doi: 10.1002/ccd.28944.
    PubMed     Abstract available


  10. LISKO J, Block PC
    The bicuspid aortic valve: Still a toothy problem.
    Catheter Cardiovasc Interv. 2020;95:1193-1194.
    PubMed     Abstract available


  11. SAIA F, Leone A
    Suprasternal access for transcatheter aortic valve implantation: All ways lead to Rome.
    Catheter Cardiovasc Interv. 2020;95:1184-1185.
    PubMed     Abstract available


    April 2020
  12. MISUMIDA N, Anderson JH, Greason KL, Rihal CS, et al
    Antegrade transseptal transcatheter aortic valve replacement: Back to the future?
    Catheter Cardiovasc Interv. 2020 Apr 30. doi: 10.1002/ccd.28934.
    PubMed     Abstract available


  13. PIAYDA K, Wimmer AC, Sievert H, Hellhammer K, et al
    Contemporary use of balloon aortic valvuloplasty and evaluation of its success in different hemodynamic entities of severe aortic valve stenosis.
    Catheter Cardiovasc Interv. 2020 Apr 27. doi: 10.1002/ccd.28950.
    PubMed     Abstract available


  14. NOGUCHI M, Tabata M, Obunai K, Shibayama K, et al
    Clinical outcomes of transcatheter aortic valve implantation (TAVI) in nonagenarians from the optimized catheter valvular intervention-TAVI registry.
    Catheter Cardiovasc Interv. 2020 Apr 25. doi: 10.1002/ccd.28935.
    PubMed     Abstract available


  15. SUN Y, Li J, Li G, Fan R, et al
    Impact of renin-angiotensin system inhibitors on outcomes after transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Apr 20. doi: 10.1002/ccd.28899.
    PubMed     Abstract available


  16. BIGNOTO TC, Le Bihan D, de Mattos Barretto RB, de Oliveira Ramos AI, et al
    Predictive role of Selvester QRS score in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Apr 16. doi: 10.1002/ccd.28905.
    PubMed     Abstract available


  17. YAP J, Chen S, Smith TWR, Rogers JH, et al
    Transjugular mitral valve repair with the MitraClip: A step-by-step guide.
    Catheter Cardiovasc Interv. 2020 Apr 7. doi: 10.1002/ccd.28902.
    PubMed     Abstract available


  18. UJIHIRA K, Kohmoto T, Gimelli G, Raval A, et al
    The impact of increased pulmonary arterial pressure on outcomes after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Apr 3. doi: 10.1002/ccd.28862.
    PubMed     Abstract available


  19. PERRINO C, Esposito G
    Diastolic dysfunction in severe aortic stenosis: Old but still gold.
    Catheter Cardiovasc Interv. 2020;95:1032-1033.
    PubMed     Abstract available


  20. TARANTINI G, Fabris T
    Transcatheter aortic valve replacement without previous conduction disturbances: The importance of preventing iatrogenic pacemaker implantation.
    Catheter Cardiovasc Interv. 2020;95:991-992.
    PubMed     Abstract available


    March 2020
  21. SCHUELER R, Ozturk C, Laser JV, Wirth F, et al
    Right ventricular assessment in patients undergoing transcatheter or surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28861.
    PubMed     Abstract available


  22. WEBER M, Jaenisch M, Spilker M, Pingel S, et al
    TAVR outcome after reclassification of aortic valve stenosis by using a hybrid continuity equation that combines computed tomography and echocardiography data.
    Catheter Cardiovasc Interv. 2020 Mar 19. doi: 10.1002/ccd.28852.
    PubMed     Abstract available


  23. MAHOWALD MK, Pislaru SV, Reeder GS, Padang R, et al
    Institutional learning experience for combined edge-to-edge tricuspid and mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Mar 17. doi: 10.1002/ccd.28856.
    PubMed     Abstract available


  24. MIURA M, Vicentini L, Taramasso M, Maisano F, et al
    Tangled wire in a Dacron band during Cardioband transcatheter tricuspid annuloplasty-How to solve the problem.
    Catheter Cardiovasc Interv. 2020 Mar 10. doi: 10.1002/ccd.28845.
    PubMed     Abstract available


  25. RAO SD, Jagasia D, Anwaruddin S, Birati EY, et al
    Response to: Prevention of thrombus formation following transcatheter aortic valve replacement in patients with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Mar 10. doi: 10.1002/ccd.28828.
    PubMed    


  26. IMAMURA T
    Prevention of thrombus formation following transcatheter aortic valve replacement in patients with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Mar 10. doi: 10.1002/ccd.28829.
    PubMed    


  27. HENSEY M, Sathananthan J, Alkhodair A, Landes U, et al
    Single-center prospective study examining use of the Wattson temporary pacing guidewire for transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Mar 9. doi: 10.1002/ccd.28832.
    PubMed     Abstract available


  28. KERN MJ, Seto AH, Ng AT, Yu JH, et al
    Effects of pericardial tamponade on the hemodynamics of aortic stenosis.
    Catheter Cardiovasc Interv. 2020 Mar 6. doi: 10.1002/ccd.28826.
    PubMed     Abstract available


  29. KHAN MZ, Khan MU, Munir MB, Khan SU, et al
    Contemporary trends and outcomes in aortic valve replacement in patients with end-stage liver disease.
    Catheter Cardiovasc Interv. 2020 Mar 4. doi: 10.1002/ccd.28834.
    PubMed     Abstract available


  30. MURDOCH DJ, Sathananthan J, Hensey M, Alu MC, et al
    Mitral regurgitation in patients undergoing transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: Insights from PARTNER 2 Valve-in-Valve Registry.
    Catheter Cardiovasc Interv. 2020 Mar 2. doi: 10.1002/ccd.28811.
    PubMed     Abstract available


  31. TARANTINI G, Fabris T
    Pure aortic valve regurgitation: SAVR is the gold standard, but TAVR is another gun.
    Catheter Cardiovasc Interv. 2020;95:817-818.
    PubMed     Abstract available


  32. ROWIN EJ, Kimmelstiel C
    Combined alcohol septal ablation and transcatheter aortic valve replacement: Drunk and playing with fire.
    Catheter Cardiovasc Interv. 2020;95:838-839.
    PubMed     Abstract available


    February 2020
  33. NITA N, Scharnbeck D, Schneider LM, Seeger J, et al
    Predictors of left ventricular reverse remodeling after percutaneous therapy for mitral regurgitation with the MitraClip system.
    Catheter Cardiovasc Interv. 2020 Feb 27. doi: 10.1002/ccd.28779.
    PubMed     Abstract available


  34. POPOVIC B, Molho A, Varlot J, Fay R, et al
    Prognostic influence of acute decompensated heart failure in patients planned for transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Feb 26. doi: 10.1002/ccd.28813.
    PubMed     Abstract available


  35. DALL'ARA G, Tumscitz C, Grotti S, Santarelli A, et al
    Contemporary balloon aortic valvuloplasty: Changing indications and refined technique.
    Catheter Cardiovasc Interv. 2020 Feb 25. doi: 10.1002/ccd.28807.
    PubMed     Abstract available


  36. VEULEMANS V, Polzin A, Piayda K, Zeus T, et al
    Early restenosis of a direct flow transcatheter aortic valve prosthesis.
    Catheter Cardiovasc Interv. 2020 Feb 24. doi: 10.1002/ccd.28806.
    PubMed     Abstract available


  37. AHMED A, Alsidawi S, Bae R, Cavalcante J, et al
    Changes in quality of life in patients with low-flow aortic stenosis undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Feb 20. doi: 10.1002/ccd.28805.
    PubMed     Abstract available


  38. REIFF C, Zhingre Sanchez JD, Mattison LM, Iaizzo PA, et al
    3-Dimensional printing to predict paravalvular regurgitation after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Feb 20. doi: 10.1002/ccd.28783.
    PubMed     Abstract available


  39. OZTURK C, Fasell T, Sinning JM, Werner N, et al
    Left atrial global function in chronic heart failure patients with functional mitral regurgitation after MitraClip.
    Catheter Cardiovasc Interv. 2020 Feb 17. doi: 10.1002/ccd.28775.
    PubMed     Abstract available


  40. RAGHUNATHAN D, Garcia-Sayan E, Dhoble A, Smalling R, et al
    First-in-human report of MitraClip G4 implantation for severe degenerative mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Feb 17. doi: 10.1002/ccd.28777.
    PubMed     Abstract available


  41. TARANTINI G, Nai Fovino L
    Impella ventricular assist device: A "valvular bypass" to support high-risk percutaneous coronary intervention or complicated transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020;95:363-364.
    PubMed    


  42. LLOYD JW, Rihal CS, Eleid MF
    Hemodynamics rounds: Hemodynamics of mitral valve interventions.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28755.
    PubMed     Abstract available


  43. ZUSMAN O, Barbash MI, Guetta V, Finkelstein A, et al
    Predicting the risk of late futile outcome after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Feb 5. doi: 10.1002/ccd.28761.
    PubMed     Abstract available


    January 2020
  44. RAO SD, Jagasia D, Anwaruddin S, Birati EY, et al
    Transcatheter aortic valve replacement thrombosis in patient supported with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Jan 24. doi: 10.1002/ccd.28742.
    PubMed     Abstract available


  45. BANDYOPADHYAY D, Sartori S, Baber U, Cao D, et al
    The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) registry.
    Catheter Cardiovasc Interv. 2020 Jan 24. doi: 10.1002/ccd.28752.
    PubMed     Abstract available


  46. SHATILA W, Krajcer Z
    Transcatheter aortic valve implantation: Do leaks matter?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28684.
    PubMed    


  47. BLOCK PC, Kumar A
    Percutaneous coronary intervention with transcatheter aortic valve replacement makes no difference! None? Really?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28686.
    PubMed     Abstract available


  48. TARANTINI G, Nai Fovino L
    Treatment of aortic stenosis in patients with chronic liver disease: Another win for transfemoral TAVR?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28690.
    PubMed     Abstract available


  49. TABACHNICK D, Obokhae B, Harrington K, Brown DL, et al
    Assessing the risk of an anomalous circumflex artery using balloon aortic valvuloplasty prior to transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28695.
    PubMed     Abstract available


  50. ZHAO ZG, Feng Y, Liao YB, Li YJ, et al
    Reshaping bicuspid aortic valve stenosis with an hourglass-shaped balloon for transcatheter aortic valve replacement: A pilot study.
    Catheter Cardiovasc Interv. 2020 Jan 14. doi: 10.1002/ccd.28726.
    PubMed     Abstract available


  51. CAMAJ A, Claessen BE, Mehran R, Yudi MB, et al
    The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO-3 trial.
    Catheter Cardiovasc Interv. 2020 Jan 13. doi: 10.1002/ccd.28717.
    PubMed     Abstract available


  52. BURZOTTA F, Aurigemma C, Romagnoli E, Shoeib O, et al
    A less-invasive totally-endovascular (LITE) technique for trans-femoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 11. doi: 10.1002/ccd.28697.
    PubMed     Abstract available


  53. NAI FOVINO L, Scotti A, Massussi M, Fabris T, et al
    Incidence and feasibility of coronary access after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28720.
    PubMed     Abstract available


    December 2019
  54. KAWAGUCHI T, Yamaji K, Ishizu K, Morinaga T, et al
    Effect of postdilatation following balloon expandable transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2019 Dec 27. doi: 10.1002/ccd.28676.
    PubMed     Abstract available


  55. LIMA FV, Kolte D, Rofeberg V, Molino J, et al
    Thirty-day readmissions after transcatheter versus surgical mitral valve repair in high-risk patients with mitral regurgitation: Analysis of the 2014-2015 Nationwide readmissions databases.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28647.
    PubMed     Abstract available


  56. NAZIR S, Ahuja KR, Donato A, Grande RD, et al
    Incidence, outcomes, and predictors of in-hospital acute coronary syndrome following endovascular transcatheter aortic valve replacement in the United States.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28648.
    PubMed     Abstract available


  57. ELEID MF, Nishimura RA
    Aortic stenosis and the pulse contour: A true marker of severity?
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28674.
    PubMed     Abstract available


  58. WINKEL MG, Brugger N, Windecker S, Praz F, et al
    An unusual cause of recurrent mitral regurgitation after percutaneous mitral valve repair.
    Catheter Cardiovasc Interv. 2019 Dec 19. doi: 10.1002/ccd.28651.
    PubMed     Abstract available


  59. DUNCAN A, Mirsadree S, Quarto C, Davies S, et al
    Transcatheter aortic valve implantation 10 years after valve-in-valve transcatheter aortic valve implantation for failing aortic valve homograft root replacement.
    Catheter Cardiovasc Interv. 2019 Dec 18. doi: 10.1002/ccd.28658.
    PubMed     Abstract available


  60. BONOW RO, O'Gara PT, Adams DH, Badhwar V, et al
    MULTISOCIETY EXPERT CONSENSUS SYSTEMS OF CARE DOCUMENT 2019 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Mitral Valve Intervention: A Joint Report of the Ame
    Catheter Cardiovasc Interv. 2019 Dec 16. doi: 10.1002/ccd.28671.
    PubMed     Abstract available


  61. HONDA Y, Araki M, Yamawaki M, Hirano K, et al
    The ARAHKEY technique: A novel method for the management of access site bleeding during percutaneous transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Dec 9. doi: 10.1002/ccd.28610.
    PubMed     Abstract available


  62. ALI Z, Sharma P, Mengesha T, Dalmar A, et al
    Early clinical and procedural outcomes in large series of 34-mm self-expanding transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28634.
    PubMed     Abstract available


  63. SCHYMIK G, Wendler O, Hengstenberg C, Ohlmann P, et al
    Outcomes of transfemoral balloon expandable transcatheter aortic valve implantation: Comparison of two subsequent valve generations.
    Catheter Cardiovasc Interv. 2019 Dec 3. doi: 10.1002/ccd.28621.
    PubMed     Abstract available


  64. HODSON RW, Jin R, Ring ME, Gafoor S, et al
    Intrathoracic complications associated with trans-femoral transcatheter aortic valve replacement: Implications for emergency surgical preparedness.
    Catheter Cardiovasc Interv. 2019 Dec 3. doi: 10.1002/ccd.28620.
    PubMed     Abstract available


    November 2019
  65. KOTRONIAS RA, Scarsini R, De Maria GL, Rajasundaram S, et al
    Ultrasound guided vascular access site management and left ventricular pacing are associated with improved outcomes in contemporary transcatheter aortic valve replacement: Insights from the OxTAVI registry.
    Catheter Cardiovasc Interv. 2019 Nov 19. doi: 10.1002/ccd.28578.
    PubMed     Abstract available


  66. ASHLEY KE, Hillegass WB
    Clopidogrel pretreatment may reduce early acquired thrombocytopenia after transcatheter aortic valve replacement (TAVR).
    Catheter Cardiovasc Interv. 2019;94:818-819.
    PubMed     Abstract available


  67. HOLLRIEGEL R, Spindler A, Kiefer P, Woitek FJ, et al
    Outcome of patients with previous coronary artery bypass grafting and severe calcific aortic stenosis receiving transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28515.
    PubMed     Abstract available


  68. FUGAR S, Behnamfar O, Okoh AK, Alabre AF, et al
    Impact of chronic thrombocytopenia on in-hospital outcomes and healthcare resource utilization after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28519.
    PubMed     Abstract available


  69. BAZARBASHI N, Ahuja K, Gad MM, Sammour YM, et al
    The utilization of single versus double Perclose devices for transfemoral aortic valve replacement access site closure: Insights from Cleveland Clinic Aortic Valve Center.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28585.
    PubMed     Abstract available


  70. DOWLING C, Firoozi S, Panoulas V, Dalby M, et al
    Initial experience of a self-expanding transcatheter aortic valve with an outer pericardial wrap: The United Kingdom and Ireland Implanters' registry.
    Catheter Cardiovasc Interv. 2019 Nov 11. doi: 10.1002/ccd.28512.
    PubMed     Abstract available


  71. ADAMS HSL, Rajani R, Hildick-Smith D, Redwood S, et al
    "Between a rock and the mitral valve space": Transcatheter mitral valve-in-valve implantation for paravalvular leak and refractory hemolysis complicated by circumflex coronary occlusion.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28573.
    PubMed     Abstract available


  72. PATEL K, Broyd C, Chehab O, Jerrum M, et al
    Transcatheter aortic valve implantation in acute decompensated aortic stenosis.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28581.
    PubMed     Abstract available


  73. PAREKH DR, Krajcer Z
    Transapical transcatheter aortic valves. Down but definitely not out for the count.
    Catheter Cardiovasc Interv. 2019;94:745.
    PubMed    


    October 2019
  74. ELBADAWI A, Elgendy IY, Mentias A, Saad M, et al
    Outcomes of urgent versus nonurgent transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Oct 24. doi: 10.1002/ccd.28563.
    PubMed     Abstract available


  75. RAJKUMAR CA, Cook C, Shalhoub J, Chukwuemeka A, et al
    Facilitating right-sided axillary artery access for transcatheter aortic valve replacement using the Edwards Sapien 3 and ultra valves: Technical considerations.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28558.
    PubMed     Abstract available


  76. GOEL S, Pasam RT, Wats K, Patel J, et al
    Transcatheter aortic valve replacement versus surgical aortic valve replacement in low-surgical-risk patients: An updated meta-analysis.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28520.
    PubMed     Abstract available


  77. DE ROSA R, Murray MI, Schranz D, Mas-Peiro S, et al
    Short-term decrease of left atrial size predicts clinical outcome in patients with severe aortic stenosis undergoing TAVR.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28542.
    PubMed     Abstract available


  78. YEOH J, Dworakowski R, Hill J, Byrne J, et al
    A contemporary and complete treatment solution for a high-risk patient with critical aortic stenosis, left ventricular thrombus, severe left ventricular dysfunction, and calcified left main stem disease.
    Catheter Cardiovasc Interv. 2019 Oct 15. doi: 10.1002/ccd.28521.
    PubMed     Abstract available


  79. COSTA G, Buccheri S, Barbanti M, Picci A, et al
    Outcomes of three different new generation transcatheter aortic valve prostheses.
    Catheter Cardiovasc Interv. 2019 Oct 14. doi: 10.1002/ccd.28524.
    PubMed     Abstract available


  80. KUNO T, Takagi H, Sugiyama T, Ando T, et al
    Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
    Catheter Cardiovasc Interv. 2019 Oct 14. doi: 10.1002/ccd.28498.
    PubMed     Abstract available


  81. SINHA S, Khan A, Qureshi AM, Suh W, et al
    Application of transcatheter valves for aortic valve replacement in pediatric patients: A case series.
    Catheter Cardiovasc Interv. 2019 Oct 14. doi: 10.1002/ccd.28505.
    PubMed     Abstract available


    September 2019
  82. DOWLING C, Kondapally Seshasai SR, Firoozi S, Brecker SJ, et al
    Transcatheter aortic valve replacement versus surgery for symptomatic severe aortic stenosis: A reconstructed individual patient data meta-analysis.
    Catheter Cardiovasc Interv. 2019 Sep 30. doi: 10.1002/ccd.28504.
    PubMed     Abstract available


  83. SATHANANTHAN J, Hensey M, Sellers S, Barlow AM, et al
    Performance of the TRUE dilatation balloon valvuloplasty catheter beyond rated burst pressure: A bench study.
    Catheter Cardiovasc Interv. 2019 Sep 30. doi: 10.1002/ccd.28503.
    PubMed     Abstract available


  84. HELMY T, Hui DS, Smart S, Lim MJ, et al
    Balloon assisted translocation of the mitral anterior leaflet to prevent left ventricular outflow obstruction (BATMAN): A novel technique for patients undergoing transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2019 Sep 13. doi: 10.1002/ccd.28496.
    PubMed     Abstract available


  85. ATTINGER-TOLLER A, Bhindi R, Perlman GY, Murdoch D, et al
    Mid-term outcome in patients with bicuspid aortic valve stenosis following transcatheter aortic valve replacement with a current generation device: A multicenter study.
    Catheter Cardiovasc Interv. 2019 Sep 4. doi: 10.1002/ccd.28475.
    PubMed     Abstract available


  86. ZHONG C, Rokey R, Rolak S, Mesa J, et al
    Pregnancy and transcatheter aortic valve replacement in a severely stenotic Freestyle full aortic root stentless bioprosthesis.
    Catheter Cardiovasc Interv. 2019 Sep 4. doi: 10.1002/ccd.28481.
    PubMed     Abstract available


  87. JOGU HR, Arora S, Strassle PD, Patel C, et al
    Impact of age and comorbidities on the effect of transcatheter versus surgical mitral valve repair on inpatient outcomes.
    Catheter Cardiovasc Interv. 2019 Sep 2. doi: 10.1002/ccd.28479.
    PubMed     Abstract available


  88. WHITBECK MG
    Treatment of focal distal abdominal aortic stenosis with the GORE VIABAHN VBX balloon expandable covered stent.
    Catheter Cardiovasc Interv. 2019 Sep 2. doi: 10.1002/ccd.28478.
    PubMed     Abstract available


  89. KORNOWSKI R
    Transcatheter aortic valve replacement for oncology patients with severe symptomatic aortic stenosis: New hope for a complicated medical condition.
    Catheter Cardiovasc Interv. 2019;94:446-447.
    PubMed     Abstract available


  90. CILINGIROGLU M, Margmakiolis K
    Predilatation for transcatheter aortic valve replacement: Still have a role?
    Catheter Cardiovasc Interv. 2019;94:479-480.
    PubMed     Abstract available


  91. ZAHR F, Cigarroa JE
    Replacing the mitral valve alone does not completely fix the heart!
    Catheter Cardiovasc Interv. 2019;94:467-468.
    PubMed     Abstract available


  92. MUSUMECI G, Cinconze S
    Relationship volume-outcome for transcatheter mitral-valve repair: When technique matters.
    Catheter Cardiovasc Interv. 2019;94:436-437.
    PubMed     Abstract available


    August 2019
  93. YOKOYAMA H, Mizuno S, Saito S
    Subacute hemolytic anemia after transcatheter edge-to-edge mitral valve repair: A case report.
    Catheter Cardiovasc Interv. 2019 Aug 30. doi: 10.1002/ccd.28482.
    PubMed     Abstract available


  94. PAGNOTTA PA, Sanz-Sanchez J, Regazzoli D, Ferrante G, et al
    One-stop-shop totally percutaneous approach for severe aortic and mitral regurgitation in cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Aug 27. doi: 10.1002/ccd.28466.
    PubMed     Abstract available


  95. RIZIK DG, Burke RF, Goldstein JA
    Urgent mechanical circulatory support and transcatheter mitral valve repair for refractory hemodynamic compromise.
    Catheter Cardiovasc Interv. 2019 Aug 27. doi: 10.1002/ccd.28439.
    PubMed     Abstract available


  96. EUDAILEY KW, Olds A, Lewis CT, Nazif TN, et al
    Contemporary suprasternal transcatheter aortic valve replacement: A multicenter experience using a simple, reliable alternative access approach.
    Catheter Cardiovasc Interv. 2019 Aug 26. doi: 10.1002/ccd.28460.
    PubMed     Abstract available


  97. HUBRECHTS J, Cools B, Brown SC, Eyskens B, et al
    Percutaneous obliteration of the right ventricle to avoid coronary damage by sinusoids in patients with pulmonary atresia intact ventricular septum during staged single ventricle palliation.
    Catheter Cardiovasc Interv. 2019 Aug 21. doi: 10.1002/ccd.28457.
    PubMed     Abstract available


  98. KANDA BS, Hoyt NE, Tavaf-Motamen H
    Paravalvular leak closure of acute mitral valve ring dehiscence during mitral valve-in-ring procedure.
    Catheter Cardiovasc Interv. 2019 Aug 20. doi: 10.1002/ccd.28443.
    PubMed     Abstract available


  99. TARANTINI G, Nai Fovino L, D'Errigo P, Rosato S, et al
    Factors influencing the choice between transcatheter and surgical treatment of severe aortic stenosis in patients younger than 80 years: Results from the OBSERVANT study.
    Catheter Cardiovasc Interv. 2019 Aug 18. doi: 10.1002/ccd.28447.
    PubMed     Abstract available


  100. ANANTHA-NARAYANAN M, Malik U, Mbai M, Megaly M, et al
    Impact of diastolic dysfunction on long-term mortality and quality of life after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Aug 16. doi: 10.1002/ccd.28444.
    PubMed     Abstract available


  101. KAMPAKTSIS PN, Vavuranakis M, Choi DY, Sherifi I, et al
    Prognostic role of diastolic dysfunction in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Aug 9. doi: 10.1002/ccd.28426.
    PubMed     Abstract available


  102. AL-ANI A, Hoffmann P, von Lueder T, Opdahl A, et al
    Safety and efficacy of hybrid vascular closure technique using both a suture- and collagen-mediated closure device after transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2019 Aug 4. doi: 10.1002/ccd.28419.
    PubMed     Abstract available


    July 2019
  103. PINO JE, Shah V, Ramos Tuarez FJ, Kreidieh OI, et al
    The utility of pulmonary function testing in the preoperative risk stratification of patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Jul 16. doi: 10.1002/ccd.28402.
    PubMed     Abstract available


  104. MOMENAH TS, Alsahari A, Ahmed E, Al Khalaf K, et al
    Transcatheter mitral valve-in-valve implantation in a pediatric patient.
    Catheter Cardiovasc Interv. 2019 Jul 11. doi: 10.1002/ccd.28390.
    PubMed     Abstract available


  105. MADUKAUWA-DAVID ID, Sadri V, Kamioka N, Midha PA, et al
    Transcatheter aortic valve deployment influences neo-sinus thrombosis risk: An in vitro flow study.
    Catheter Cardiovasc Interv. 2019 Jul 9. doi: 10.1002/ccd.28388.
    PubMed     Abstract available


    June 2019
  106. KERN MJ, Kim M, Yu J, Seto AH, et al
    Evaluation of the severity of mitral stenosis in patient with pulmonary hypertension: Role of exercise hemodynamics.
    Catheter Cardiovasc Interv. 2019 Jun 27. doi: 10.1002/ccd.28381.
    PubMed     Abstract available


  107. NANJUDAPPA A, Bhagat A, Bates MC
    A rare cause of stroke after transcatheter aortic valve replacement: Retained foreign body.
    Catheter Cardiovasc Interv. 2019 Jun 24. doi: 10.1002/ccd.28374.
    PubMed     Abstract available


  108. WERNER N, Puls M, Baldus S, Lubos E, et al
    Gender-related differences in patients undergoing transcatheter mitral valve interventions in clinical practice: 1-year results from the German TRAMI registry.
    Catheter Cardiovasc Interv. 2019 Jun 24. doi: 10.1002/ccd.28372.
    PubMed     Abstract available


  109. KEYMEL S, Papadopoulos G, Minol JP, Blehm A, et al
    Patients with severe aortic stenosis and coexisting pulmonary hypertension treated by transapical transcatheter aortic valve replacement-Is there a need for increased attention?
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28358.
    PubMed     Abstract available


  110. STACHON P, Kaier K, Heidt T, Bothe W, et al
    Nationwide outcomes of aortic valve replacement for pure aortic regurgitation in Germany 2008-2015.
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28361.
    PubMed     Abstract available


  111. BLOCK PC, Lisko JC
    Thrombocytopenia after transcatheter aortic valve replacement: What is really going on?
    Catheter Cardiovasc Interv. 2019;93:1352-1353.
    PubMed     Abstract available


    May 2019
  112. AMAT-SANTOS IJ, Gutierrez H, Sathananthan J, Webb JG, et al
    Fracture of small Mitroflow(R) aortic bioprosthesis following valve-in-valve transcatheter aortic valve replacement with ACURATE neo valve-From bench testing to clinical practice.
    Catheter Cardiovasc Interv. 2019 May 29. doi: 10.1002/ccd.28347.
    PubMed     Abstract available


  113. CONZELMANN LO, Wurth A, Balthasar V, Neuber C, et al
    Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28339.
    PubMed     Abstract available


  114. KOYAMA Y, Yamamoto M, Kagase A, Tsujimoto S, et al
    Prognostic impact and periprocedural complications of chronic steroid therapy in patients following transcatheter aortic valve replacement: Propensity-matched analysis from the Japanese OCEAN registry.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28332.
    PubMed     Abstract available


  115. UESHIMA D, Barioli A, Nai Fovino L, D'Amico G, et al
    The impact of pre-existing peripheral artery disease on transcatheter aortic valve implantation outcomes: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2019 May 17. doi: 10.1002/ccd.28335.
    PubMed     Abstract available


  116. OJEDA S, Hidalgo F, Romero M, Mazuelos F, et al
    Impact of the repositionable Evolut R CoreValve system on the need for a permanent pacemaker after transcatheter aortic valve implantation in patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2019 May 7. doi: 10.1002/ccd.28327.
    PubMed     Abstract available


  117. IBRAHIM H, Vapheas E, Shah B, AlKhalil A, et al
    Preprocedural P2Y12 inhibition and decrease in platelet count following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 May 6. doi: 10.1002/ccd.28320.
    PubMed     Abstract available


  118. ASHLEY KE, Hillegass WB
    Costs of postoperative delirium with transcatheter aortic valve replacement: Improved yet still present.
    Catheter Cardiovasc Interv. 2019;93:1137.
    PubMed     Abstract available


    April 2019
  119. ATTINGER-TOLLER A, Htun NM, Murdoch D, Perlman GY, et al
    Transcatheter aortic valve-in-valve implantation for failed surgical bioprosthetic valves. A minimalist approach without contrast aortography or echocardiographic guidance.
    Catheter Cardiovasc Interv. 2019 Apr 30. doi: 10.1002/ccd.28299.
    PubMed     Abstract available


  120. JUNQUERA L, Freitas-Ferraz AB, Padron R, Silva I, et al
    Intraprocedural high-degree atrioventricular block or complete heart block in transcatheter aortic valve replacement recipients with no prior intraventricular conduction disturbances.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28323.
    PubMed     Abstract available


  121. SEPPELT PC, Zappel J, Weiler H, Mas-Peiro S, et al
    Aortic valve replacement in patients with preexisting liver disease: Transfemoral approach with favorable survival.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28319.
    PubMed     Abstract available


  122. MOHANANEY D, Villablanca P, Gupta T, Ranka S, et al
    Association of peripheral artery disease with in-hospital outcomes after endovascular transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Apr 25. doi: 10.1002/ccd.28310.
    PubMed     Abstract available


  123. DE MIGUEL-DIEZ J, Lopez-de-Andres A, Hernandez-Barrera V, Mendez-Bailon M, et al
    Impact of COPD on outcomes in hospitalized patients treated with transcatheter aortic valve implantation or surgical aortic valve replacement in Spain.
    Catheter Cardiovasc Interv. 2019 Apr 25. doi: 10.1002/ccd.28321.
    PubMed     Abstract available


  124. ZHOU D, Pan W, Wang J, Wu Y, et al
    VitaFlow transcatheter valve system in the treatment of severe aortic stenosis: One-year results of a multicenter study.
    Catheter Cardiovasc Interv. 2019 Apr 24. doi: 10.1002/ccd.28226.
    PubMed     Abstract available


  125. NISHIMURA RA, O'Gara PT, Bavaria JE, Brindis RG, et al
    2019 AATS/ACC/ASE/SCAI/STS expert consensus systems of care document: A proposal to optimize care for patients with valvular heart disease: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, American Socie
    Catheter Cardiovasc Interv. 2019 Apr 19. doi: 10.1002/ccd.28196.
    PubMed    


  126. BERI N, Singh GD, Smith TW, Fan D, et al
    Iatrogenic atrial septal defect closure after transseptal mitral valve interventions: Indications and outcomes.
    Catheter Cardiovasc Interv. 2019 Apr 19. doi: 10.1002/ccd.28294.
    PubMed     Abstract available


  127. YOSHIJIMA N, Yanagisawa R, Hase H, Tanaka M, et al
    Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2019 Apr 11. doi: 10.1002/ccd.28279.
    PubMed     Abstract available


  128. RAJ L, Mehra A, Shavelle DM
    Mixed aortic valve disease treated with transcatheter aortic valve replacement in a high risk patient presenting with acute decompensated heart failure.
    Catheter Cardiovasc Interv. 2019 Apr 10. doi: 10.1002/ccd.28221.
    PubMed     Abstract available


  129. LANE CE, Eleid MF, Holmes DR Jr
    An under-recognized high-risk atrial fibrillation population: Analyzing transcatheter mitral valve repair patients for left atrial appendage closure device application.
    Catheter Cardiovasc Interv. 2019 Apr 5. doi: 10.1002/ccd.28220.
    PubMed     Abstract available


  130. MARMAGKIOLIS K, Hakeem A, Ebersole DG, Iliescu C, et al
    Clinical outcomes of percutaneous mitral valve repair with MitraClip for the management of functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2019 Apr 1. doi: 10.1002/ccd.28203.
    PubMed     Abstract available


  131. SAFI LM, Turi ZG
    A match not made in heaven-TAVR prosthesis-patient mismatch with contemporary valves.
    Catheter Cardiovasc Interv. 2019;93:980-981.
    PubMed     Abstract available


    March 2019
  132. AKTUERK D, Jansz P, Shaw M, Muller DWM, et al
    Successful repositioning of apically tethered transcatheter mitral valve replacement in the off-bypass, beating heart.
    Catheter Cardiovasc Interv. 2019 Mar 27. doi: 10.1002/ccd.28210.
    PubMed     Abstract available


  133. SAIA F, Palmerini T, Compagnone M, Battistini P, et al
    Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2019 Mar 27. doi: 10.1002/ccd.28211.
    PubMed     Abstract available


  134. ABAWI M, van Gils L, Agostoni P, van Mieghem NM, et al
    Impact of baseline cigarette smoking status on clinical outcome after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Mar 22. doi: 10.1002/ccd.28175.
    PubMed     Abstract available


  135. BUTTER C, Okamoto M, Schymik G, Jacobshagen C, et al
    Degree of valve calcification in patients undergoing transfemoral transcatheter aortic valve implantation with and without balloon aortic valvuloplasty: Findings from the multicenter EASE-IT TF registry.
    Catheter Cardiovasc Interv. 2019 Mar 13. doi: 10.1002/ccd.28164.
    PubMed     Abstract available


  136. BELARDI JA, Lamelas PM
    Transcatheter aortic valve replacement hemodynamic durability: Still in question?
    Catheter Cardiovasc Interv. 2019;93:739.
    PubMed     Abstract available


  137. KUMAR V, Seth A
    Transcatheter aortic valve replacement: Protect the kidneys to protect the patient.
    Catheter Cardiovasc Interv. 2019;93:749-750.
    PubMed     Abstract available


  138. SHATILA W, Krajcer Z
    TAVI: How to best predict postprocedural outcomes?
    Catheter Cardiovasc Interv. 2019;93:E261.
    PubMed     Abstract available


  139. GILCHRIST IC
    Treating hemolysis due to perivalvular leaks: It is all about modifying micro-jets and not the volume of regurgitation.
    Catheter Cardiovasc Interv. 2019;93:720-721.
    PubMed     Abstract available


    February 2019
  140. UESHIMA D, Masiero G, Schiavo A, Badawy MRA, et al
    Time course of the survival advantage of transcatheter over surgical aortic valve replacement: Interplay between sex and patient risk profile.
    Catheter Cardiovasc Interv. 2019 Feb 28. doi: 10.1002/ccd.28124.
    PubMed     Abstract available


  141. AL-OGAILI A, Fugar S, Okoh A, Kolkailah AA, et al
    Trends in complete heart block after transcatheter aortic valve replacement: A population based analysis.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28156.
    PubMed     Abstract available


  142. LLOYD JW, Joseph TA, Cabalka AK, Guerrero M, et al
    Hemodynamic and clinical response to transseptal mitral valve-in-valve and valve-in-ring.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28149.
    PubMed     Abstract available


  143. ABBAS AE, Pibarot P
    Hemodynamic characterization of aortic stenosis states.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28146.
    PubMed     Abstract available


  144. JAMES TM, Stamou SC, Rothenberg M, Nores MA, et al
    Transcatheter aortic valve in valve implantation with bioprosthetic valve fracture.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28113.
    PubMed     Abstract available


  145. D'ANCONA G, Ince H, Schillinger W, Senges J, et al
    Percutaneous treatment of mitral regurgitation in patients with impaired ventricular function: Impact of intracardiac electronic devices (from the German Transcatheter Mitral Valve Interventions Registry).
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28127.
    PubMed     Abstract available


  146. BLACKMAN DJ, Van Gils L, Bleiziffer S, Gerckens U, et al
    Clinical outcomes of the Lotus Valve in patients with bicuspid aortic valve stenosis: An analysis from the RESPOND study.
    Catheter Cardiovasc Interv. 2019 Feb 17. doi: 10.1002/ccd.28120.
    PubMed     Abstract available


  147. TAKAYUKI G, Volker H, Axel H, Dirk F, et al
    Transfemoral transcatheter aortic valve implantation after aortic valve repair with HAART 300 device.
    Catheter Cardiovasc Interv. 2019 Feb 17. doi: 10.1002/ccd.28129.
    PubMed     Abstract available


  148. PAREKH DR, Krajcer Z
    Percutaneous pulmonary valve implantation: It's not like the aortic valve.
    Catheter Cardiovasc Interv. 2019;93:464-465.
    PubMed     Abstract available


  149. CHEN B, Dean LS
    HAS-BLED for predicting transfemoral transcatheter aortic valve replacement outcomes: Enough to tamponade the problem?
    Catheter Cardiovasc Interv. 2019;93:E202-E203.
    PubMed     Abstract available


  150. KHAN A, Dangas G
    Positioning of self-expanding transcatheter valve prostheses.
    Catheter Cardiovasc Interv. 2019;93:530-531.
    PubMed     Abstract available


  151. SINHA S, Aboulhosn J, Asnes J, Bocks M, et al
    Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi-institutional experience.
    Catheter Cardiovasc Interv. 2019;93:455-463.
    PubMed     Abstract available


  152. JOLLEY MA, Lasso A, Nam HH, Dinh PV, et al
    Toward predictive modeling of catheter-based pulmonary valve replacement into native right ventricular outflow tracts.
    Catheter Cardiovasc Interv. 2019;93:E143-E152.
    PubMed     Abstract available


  153. HO AB, Kaarne M, Mullen M, Hayes N, et al
    Hybrid transcatheter tricuspid valve-in-valve placement of an Edwards Sapien XT valve in palliated hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2019;93:481-483.
    PubMed     Abstract available


  154. MORRAY BH, Jones TK, Coe JY, Gitter R, et al
    Implantation of the Melody transcatheter pulmonary valve PB1016 in patients with dysfunctional right ventricular outflow tract conduits.
    Catheter Cardiovasc Interv. 2019;93:474-480.
    PubMed     Abstract available


  155. SHAHANAVAZ S, Rockefeller T, Nicolas R, Balzer D, et al
    Modified delivery of SAPIEN 3 valve in the pulmonary position: Evolution of technique or dire need?
    Catheter Cardiovasc Interv. 2019;93:484-487.
    PubMed     Abstract available


  156. HACHINOHE D, Latib A, Laricchia A, Demir OM, et al
    Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation.
    Catheter Cardiovasc Interv. 2019;93:522-529.
    PubMed     Abstract available


  157. AL-HIJJI MA, El Sabbagh A, Guerrero ME, Rihal CS, et al
    Paravalvular leak repair after balloon-expandable transcatheter mitral valve implantation in mitral annular calcification: Early experience and lessons learned.
    Catheter Cardiovasc Interv. 2019 Feb 9. doi: 10.1002/ccd.28131.
    PubMed     Abstract available


  158. BELARDI J, Lamelas P
    TAVR for aortic valve regurgitation: Ready for a randomized trial?
    Catheter Cardiovasc Interv. 2019;93:354-355.
    PubMed     Abstract available


  159. MORGAN GJ, Sadeghi S, Salem MM, Wilson N, et al
    SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without "pre-stenting": A multi-institutional experience.
    Catheter Cardiovasc Interv. 2019;93:324-329.
    PubMed     Abstract available


    January 2019
  160. AL-HIJJI MA, Zack CJ, Nkomo VT, Pislaru SV, et al
    Left ventricular remodeling and function after transapical versus transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Jan 27. doi: 10.1002/ccd.28074.
    PubMed     Abstract available


  161. BUTERA G, Hansen JH, Jones MI
    Tricuspid regurgitation complicating SAPIEN 3 valve implantation in pulmonary position.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28083.
    PubMed    


  162. RATTANAWONG P, Kanitsoraphan C, Kewcharoen J, Riangwiwat T, et al
    Chronic kidney disease is associated with increased mortality and procedural complications in transcatheter aortic valve replacement: a systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28102.
    PubMed     Abstract available


  163. FLINT K, Brieke A, Wiktor D, Carroll J, et al
    Percutaneous edge-to-edge mitral valve repair may rescue select patients in cardiogenic shock: Findings from a single center case series.
    Catheter Cardiovasc Interv. 2019 Jan 24. doi: 10.1002/ccd.28089.
    PubMed     Abstract available


  164. OKOH AK, Haik N, Singh S, Kaur K, et al
    Discharge disposition of older patients undergoing trans-catheter aortic valve replacement and its impact on survival.
    Catheter Cardiovasc Interv. 2019 Jan 7. doi: 10.1002/ccd.28069.
    PubMed     Abstract available


  165. ALDERWEIRELDT AS, De Wolf D
    Percutaneous closure of paravalvular leak after Cone repair for Ebstein's anomaly.
    Catheter Cardiovasc Interv. 2019;93:E46-E48.
    PubMed     Abstract available


    December 2018
  166. CHEN L, Mantri N, Eng ML, Wung W, et al
    Intraprocedural direct left atrial and wedge pressure correlation during transcatheter mitral valve repair: Results from a single center registry.
    Catheter Cardiovasc Interv. 2018 Dec 27. doi: 10.1002/ccd.28035.
    PubMed     Abstract available


  167. CHOI CH, Cheng V, Malaver D, Kon N, et al
    A comparison of valve-in-valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves.
    Catheter Cardiovasc Interv. 2018 Dec 27. doi: 10.1002/ccd.28039.
    PubMed     Abstract available


  168. ELGENDY IY, Mahmoud AN, Elbadwai A, Elgendy AY, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement for nonagenarians.
    Catheter Cardiovasc Interv. 2018 Dec 19. doi: 10.1002/ccd.28050.
    PubMed     Abstract available


  169. POTTER BJ, Thompson C, Green P, Clancy S, et al
    Incremental cost and length of stay associated with postprocedure delirium in transcatheter and surgical aortic valve replacement patients in the United States.
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28014.
    PubMed     Abstract available


  170. SCHECHTER M, Balanescu DV, Donisan T, Dayah TJ, et al
    An update on the management and outcomes of cancer patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28052.
    PubMed     Abstract available


  171. FINKELSTEIN A, Rozenbaum Z, Zhitomirsky S, Halkin A, et al
    Safety outcomes of new versus old generation transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2018 Dec 13. doi: 10.1002/ccd.28021.
    PubMed     Abstract available


  172. FERNANDEZ-LOPEZ L, Chevalier B, Lefevre T, Spaziano M, et al
    Implementation of the transradial approach as an alternative vascular access for transcatheter aortic valve replacement guidance: Experience from a high-volume center.
    Catheter Cardiovasc Interv. 2018 Dec 10. doi: 10.1002/ccd.28024.
    PubMed     Abstract available


  173. GUEDENEY P, Tchetche D, Petronio AS, Mehilli J, et al
    Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.
    Catheter Cardiovasc Interv. 2018 Dec 4. doi: 10.1002/ccd.28012.
    PubMed     Abstract available


  174. AHMED A, Akintoye E, Adegbala O, Yassin A, et al
    In-hospital outcomes of transcatheter mitral valve repair with Mitraclip in patients with pulmonary hypertension: Insights from the National Inpatient Sample.
    Catheter Cardiovasc Interv. 2018 Dec 2. doi: 10.1002/ccd.27997.
    PubMed     Abstract available


  175. KHAN A, Dangas G
    Transcatheter valve-in-valve for failing bioprosthetic aortic valve: Usually a good idea.
    Catheter Cardiovasc Interv. 2018;92:1412-1413.
    PubMed     Abstract available


    November 2018
  176. YOUNIS A, Orvin K, Nof E, Barabash IM, et al
    The effect of periprocedural beta blocker withdrawal on arrhythmic risk following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Nov 29. doi: 10.1002/ccd.28017.
    PubMed     Abstract available


  177. TAKAGI H, Hari Y, Kawai N, Ando T, et al
    Impact of concurrent tricuspid regurgitation on mortality after transcatheter aortic-valve implantation.
    Catheter Cardiovasc Interv. 2018 Nov 25. doi: 10.1002/ccd.27948.
    PubMed     Abstract available


  178. JACOBZON E, Wolak A, Fink D, Silberman S, et al
    Delayed aortic dissection and valve thrombosis after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27994.
    PubMed     Abstract available


  179. ABDELGHANI M, Allali A, Kaur J, Hemetsberger R, et al
    Impact of prosthesis-iteration evolution and sizing practice on the incidence of prosthesis-patient mismatch after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27977.
    PubMed     Abstract available


  180. BROUWER J, Gheorghe L, Nijenhuis VJ, Ten Berg JM, et al
    Insight on patient specific computer modeling of transcatheter aortic valve implantation in patients with bicuspid aortic valve disease.
    Catheter Cardiovasc Interv. 2018 Nov 20. doi: 10.1002/ccd.27990.
    PubMed     Abstract available


  181. JOSEPH TA, Eleid MF, Cabalka AK, Maalouf JF, et al
    Long-term outcomes of melody valve-in-valve implantation for bioprosthetic mitral valve dysfunction.
    Catheter Cardiovasc Interv. 2018 Nov 20. doi: 10.1002/ccd.27988.
    PubMed     Abstract available


  182. LEHNER A, Herrmann FE, Mehilli J, Haas NA, et al
    Edwards Sapien 3 transcatheter aortic valve implantation for management of severe aortic regurgitation in a teenage patient with corrected atrioventricular septal defect and progressive left ventricular dysfunction.
    Catheter Cardiovasc Interv. 2018 Nov 20. doi: 10.1002/ccd.27975.
    PubMed     Abstract available


  183. MODOLO R, Miyazaki Y, Chang CC, Te Lintel Hekkert M, et al
    Feasibility study of a synchronized diastolic injection with low contrast volume for proper quantitative assessment of aortic regurgitation in porcine models.
    Catheter Cardiovasc Interv. 2018 Nov 15. doi: 10.1002/ccd.27972.
    PubMed     Abstract available


  184. CHENG R, Kar S, Siegel RJ, Nakamura M, et al
    Cleft mitral leaflets and severe mitral regurgitation: Testing the limits of percutaneous mitral valve repair.
    Catheter Cardiovasc Interv. 2018 Nov 15. doi: 10.1002/ccd.27980.
    PubMed     Abstract available


  185. PAN W, Pan C, Jilaihawi H, Wei L, et al
    A novel user-friendly transcatheter edge-to-edge mitral valve repair device in a porcine model.
    Catheter Cardiovasc Interv. 2018 Nov 15. doi: 10.1002/ccd.27976.
    PubMed     Abstract available


  186. BUTTER C, Kaneko H, Tambor G, Hara M, et al
    Clinical utility of intraprocedural three-dimensional integrated image guided transcatheter aortic valve implantation using novel automated computed tomography software: A single-center preliminary experience.
    Catheter Cardiovasc Interv. 2018 Nov 8. doi: 10.1002/ccd.27920.
    PubMed     Abstract available


  187. SPINA R, Khalique O, Kodali S, Bapat VN, et al
    Urgent transcatheter aortic valve replacement for severe acute aortic regurgitation following open mitral valve surgery.
    Catheter Cardiovasc Interv. 2018 Nov 8. doi: 10.1002/ccd.27954.
    PubMed     Abstract available


  188. ANDO T, Adegbala O, Villablanca PA, Briasoulis A, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement in non-teaching hospitals.
    Catheter Cardiovasc Interv. 2018 Nov 8. doi: 10.1002/ccd.27968.
    PubMed     Abstract available


  189. DOWLING C, Firoozi S, Doyle N, Blackman DJ, et al
    Initial experience of a large, self-expanding, and fully recapturable transcatheter aortic valve: The UK & Ireland Implanters' registry.
    Catheter Cardiovasc Interv. 2018 Nov 5. doi: 10.1002/ccd.27934.
    PubMed     Abstract available


  190. KUMAR A, Block PC
    Paravalvular leak after transcatheter aortic valve replacement: Avoid it or treat it if you can!
    Catheter Cardiovasc Interv. 2018;92:981-982.
    PubMed     Abstract available


    October 2018
  191. MORRICAL BD, Dearani JA, Cabalka AK
    Melody valve in mitral position: Complete fracture causing acute mitral stenosis in a child.
    Catheter Cardiovasc Interv. 2018 Oct 31. doi: 10.1002/ccd.27683.
    PubMed     Abstract available


  192. BEN-DOR I, Rogers T, Satler LF, Waksman R, et al
    A word of caution using self-expanding transcatheter aortic valve-frame infolding.
    Catheter Cardiovasc Interv. 2018 Oct 30. doi: 10.1002/ccd.27870.
    PubMed     Abstract available


  193. THONGHONG T, Bieliauskas G, De Backer O, Sondergaard L, et al
    Economical cost of percutaneous vascular closure with ProGlide and Prostar XL following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 22. doi: 10.1002/ccd.27697.
    PubMed    


  194. PINEDA AM, Kevin Harrison J, Kleiman NS, Reardon MJ, et al
    Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 20. doi: 10.1002/ccd.27928.
    PubMed     Abstract available


  195. SPIEKER M, Hellhammer K, Wiora J, Klose S, et al
    Prognostic value of impaired hepato-renal function assessed by the MELD-XI score in patients undergoing percutaneous mitral valve repair.
    Catheter Cardiovasc Interv. 2018 Oct 17. doi: 10.1002/ccd.27906.
    PubMed     Abstract available


  196. KUMAR A, Sato K, Banerjee K, Narayanswami J, et al
    Hemodynamic durability of transcatheter aortic valves using the updated Valve Academic Research Consortium-2 criteria.
    Catheter Cardiovasc Interv. 2018 Oct 12. doi: 10.1002/ccd.27927.
    PubMed     Abstract available


  197. LI J, Patel SM, Nadeem F, Thakker P, et al
    Impact of residual coronary atherosclerosis on transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 12. doi: 10.1002/ccd.27894.
    PubMed     Abstract available


  198. MISUMIDA N, Pagath M, Ogunbayo GO, Wilson RE, et al
    Characteristics of and current practice patterns of pacing for high-degree atrioventricular block after transcatheter aortic valve implantation in comparison to surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 9. doi: 10.1002/ccd.27915.
    PubMed     Abstract available


  199. KESSLER M, Gonska B, Seeger J, Rottbauer W, et al
    Long-term clinical outcome of persistent left bundle branch block after transfemoral aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Oct 8. doi: 10.1002/ccd.27850.
    PubMed     Abstract available


  200. NELSON BC, Chadderdon S, Song H, Zahr FE, et al
    Bioprosthetic aortic valve leaflet disruption with high energy electrocautery to prevent coronary artery obstruction during valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 8. doi: 10.1002/ccd.27721.
    PubMed     Abstract available


  201. BUCHANAN KD, Rogers T, Steinvil A, Koifman E, et al
    Role of contractile reserve as a predictor of mortality in low-flow, low-gradient severe aortic stenosis following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 2. doi: 10.1002/ccd.27914.
    PubMed     Abstract available


    September 2018
  202. RAWASIA WF, Khan MS, Usman MS, Siddiqi TJ, et al
    Safety and efficacy of transcatheter aortic valve replacement for native aortic valve regurgitation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27840.
    PubMed     Abstract available


  203. MAS-PEIRO S, Weiler H, Papadopoulos N, Zeiher AM, et al
    Post/preprocedural ratio of hemodynamically assessed aortic regurgitation index as a marker for the need for corrective measures during transcatheter valve replacement: A first confirmatory study in patients receiving a new generation transcatheter se
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27847.
    PubMed     Abstract available


  204. MORI M, Bin Mahmood SU, Geirsson A, Yun JJ, et al
    Trends in volume and risk profiles of patients undergoing isolated surgical and transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27855.
    PubMed     Abstract available


  205. EDRIS A, Bartel T, Tuzcu EM, Suri RM, et al
    Alcohol septal ablation for outflow tract obstruction after transcatheter aortic and mitral valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27723.
    PubMed     Abstract available


  206. DENEGRI A, Mehran R, Holy E, Taramasso M, et al
    Post procedural risk assessment in patients undergoing trans aortic valve implantation according to the age, creatinine, and ejection fraction-7 score: Advantages of age, creatinine, and ejection fraction-7 in stratification of post-procedural outcome
    Catheter Cardiovasc Interv. 2018 Sep 30:e27806. doi: 10.1002/ccd.27806.
    PubMed     Abstract available


  207. KESSLER M, Seeger J, Wohrle J, Rottbauer W, et al
    Intra-aortic balloon counterpulsation pump in heart failure patients during MitraClip implantation-A propensity-score matched analysis.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27717.
    PubMed     Abstract available


  208. ALQAHTANI F, Ziada K, Rihal CS, Alkhouli M, et al
    Incidence and outcomes of early percutaneous coronary intervention after isolated valve surgery.
    Catheter Cardiovasc Interv. 2018 Sep 30:e27874. doi: 10.1002/ccd.27874.
    PubMed     Abstract available


  209. MADUKAUWA-DAVID ID, Midha PA, Sharma R, McLain K, et al
    Characterization of aortic root geometry in transcatheter aortic valve replacement patients.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27805.
    PubMed     Abstract available


  210. BAVARIA JE, Tommaso CL, Brindis RG, Carroll JD, et al
    MULTISOCIETY EXPERT CONSENSUS SYSTEMS OF CARE DOCUMENT 2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27811.
    PubMed    


  211. HERNANDEZ-ENRIQUEZ M, Regueiro A, Romaguera R, Andrea R, et al
    Thrombocytopenia after transcatheter aortic valve implantation. A comparison between balloon-expandable and self-expanding valves.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27907.
    PubMed     Abstract available


  212. RAPHAEL CE, Malouf JF, Maor E, Panaich SS, et al
    A hybrid technique for treatment of commissural primary mitral regurgitation.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27904.
    PubMed     Abstract available


  213. GARCIA S, Mbai M, Kelly R, Bertog S, et al
    Simultaneous transfemoral transcatheter aortic valve replacement and trans-septal mitral valve-in-ring implantation after partial laceration of an Alfieri stitch.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27875.
    PubMed     Abstract available


  214. PIAYDA K, Hellhammer K, Veulemans V, Zeus T, et al
    Valvuloplasty balloon entrapment in a self-expanding aortic valve stent frame after inadvertent wire passage through the outflow struts.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27858.
    PubMed     Abstract available


  215. ATHAYDE GRS, Nascimento BR, Elmariah S, Lodi-Junqueira L, et al
    Impact of left atrial compliance improvement on functional status after percutaneous mitral valvuloplasty.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27831.
    PubMed     Abstract available


  216. LAZKANI M, Sawant AC, Taase A, Khan S, et al
    Left atrial hemodynamics and left ventricular remodeling -predictors of outcomes after Transcatheter mitral valve repair with the MitraClip device.
    Catheter Cardiovasc Interv. 2018 Sep 23:e27804. doi: 10.1002/ccd.27804.
    PubMed     Abstract available


  217. DADU RT, Xu J, Rehman H, von Ballmoos MW, et al
    Optimal positioning of self-expanding valves before deployment decreases paravalvular regurgitation following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27829.
    PubMed     Abstract available


  218. RASHID HN, Nasis A, Gooley RP, Cameron JD, et al
    The prevalence of computed tomography-defined leaflet thrombosis in intra- versus supra-annular transcatheter aortic valve prostheses.
    Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27702.
    PubMed     Abstract available


  219. VAN MOURIK MS, Janmaat YC, van Kesteren F, Vendrik J, et al
    CT determined psoas muscle area predicts mortality in women undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27823.
    PubMed     Abstract available


  220. BRAUN D, Nabauer M, Massberg S, Hausleiter J, et al
    One-stop shop: Simultaneous direct mitral annuloplasty and percutaneous mitral edge-to-edge repair in a patient with severe mitral regurgitation.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27848.
    PubMed     Abstract available


  221. GORLA R, Cannone GS, Bedogni F, De Marco F, et al
    Transfemoral aortic valve implantation following lithoplasty of iliac artery in a patient with poor vascular access.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27812.
    PubMed     Abstract available


    August 2018
  222. ATTISANO T, Silverio A, Stabile E, Briguori C, et al
    Safety and feasibility of balloon aortic valvuloplasty in non-TAVI centers: The "BAV for life" experience.
    Catheter Cardiovasc Interv. 2018 Aug 25. doi: 10.1002/ccd.27820.
    PubMed     Abstract available


  223. AZIZ M, Simonato M, Webb JG, Abdel-Wahab M, et al
    Mortality prediction after transcatheter treatment of failed bioprosthetic aortic valves utilizing various international scoring systems: Insights from the Valve-in-Valve International Data (VIVID).
    Catheter Cardiovasc Interv. 2018 Aug 5. doi: 10.1002/ccd.27714.
    PubMed     Abstract available


  224. LLOYD JW, Reeder GS, Rihal CS, Eleid MF, et al
    Effect of saline administration on left atrial pressure during transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2018 Aug 5. doi: 10.1002/ccd.27710.
    PubMed     Abstract available


  225. KHAN JM, Lederman RJ
    Adventures across the second dimension: Predicting left ventricular outflow tract obstruction following transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2018;92:388-389.
    PubMed    


  226. LEMOS PA, Makdisse M
    The less complex the case is, the more complex is it to choose? The case of lower risk patients with aortic valve stenosis.
    Catheter Cardiovasc Interv. 2018;92:399-400.
    PubMed    


  227. CHATTERJEE A, Hillegass WB
    Surgical aortic valve replacement and transcatheter aortic valve implantation for severe aortic stenosis: Equipoise remains a tenable assumption.
    Catheter Cardiovasc Interv. 2018;92:431-432.
    PubMed    


    July 2018
  228. TAM DY, Vo TX, Wijeysundera HC, Dvir D, et al
    Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Jul 19. doi: 10.1002/ccd.27686.
    PubMed     Abstract available


  229. ROGERS T, Gai J, Torguson R, Okubagzi PG, et al
    Predicted magnitude of alternate access in the contemporary transcatheter aortic valve replacement era.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27668.
    PubMed     Abstract available


  230. MAKKI N, Ghao X, Whitson B, Shreenivas S, et al
    Slope of left ventricular filling as an index of valvular and paravalvular regurgitation in native and prosthetic aortic valves.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27684.
    PubMed     Abstract available


  231. UESHIMA D, Nai Fovino L, Mojoli M, Napodano M, et al
    The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27681.
    PubMed     Abstract available


  232. DAMLUJI AA, Murman M, Byun S, Moscucci M, et al
    Alternative access for transcatheter aortic valve replacement in older adults: A collaborative study from France and United States.
    Catheter Cardiovasc Interv. 2018 Jul 3. doi: 10.1002/ccd.27690.
    PubMed     Abstract available


    June 2018
  233. BLOCK PC
    Transcatheter treatment of aortic regurgitation: Still enigmatic.
    Catheter Cardiovasc Interv. 2018;91:1352-1353.
    PubMed     Abstract available


    May 2018
  234. HACHINOHE D, Latib A, Montorfano M, Colombo A, et al
    Transcatheter mitral valve implantation in rigid mitral annuloplasty rings: Potential differences between complete and incomplete rings.
    Catheter Cardiovasc Interv. 2018 May 18. doi: 10.1002/ccd.27658.
    PubMed     Abstract available


  235. ASMARATS L, Rodriguez-Gabella T, Chamandi C, Bernier M, et al
    Infective endocarditis following transcatheter edge-to-edge mitral valve repair: A systematic review.
    Catheter Cardiovasc Interv. 2018 May 10. doi: 10.1002/ccd.27632.
    PubMed     Abstract available


    April 2018
  236. VILLABLANCA PA, Mohananey D, Ramakrishna H
    Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: An updated meta-analysis.
    Catheter Cardiovasc Interv. 2018 Apr 16. doi: 10.1002/ccd.27639.
    PubMed    


  237. SAJI M, Katz MR, Ailawadi G, Welch TS, et al
    6-Minute walk test predicts prolonged hospitalization in patients undergoing transcatheter mitral valve repair by MitraClip.
    Catheter Cardiovasc Interv. 2018 Apr 15. doi: 10.1002/ccd.27600.
    PubMed     Abstract available


  238. DE BACKER O, Sondergaard L
    TAVR in bicuspid aortic valve stenosis: "We are not there yet" to draw final conclusions.
    Catheter Cardiovasc Interv. 2018;91:984-985.
    PubMed     Abstract available


  239. KRISHNAN SK, Dean LS
    Looking for the bare necessities.
    Catheter Cardiovasc Interv. 2018;91:956-957.
    PubMed     Abstract available


  240. BURZOTTA F, Trani C
    TAVR technique tries to go higher than bicuspid valve hurdles.
    Catheter Cardiovasc Interv. 2018;91:995-996.
    PubMed     Abstract available


    March 2018
  241. YE J, Lee AJ, Blanke P, Webb J, et al
    The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27604.
    PubMed     Abstract available


  242. KINDYA B, Ouzan E, Lerakis S, Gonen E, et al
    Degenerative mitral regurgitation predicts worse outcomes in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27607.
    PubMed     Abstract available


  243. HONDA Y, Yamawaki M, Araki M, Tada N, et al
    Impact of HAS-BLED score to predict trans femoral transcatheter aortic valve replacement outcomes.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27596.
    PubMed     Abstract available


  244. DE PALMA R, Settergren M, Ruck A, Linder R, et al
    Impact of percutaneous femoral arteriotomy closure using the MANTA(TM) device on vascular and bleeding complications after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Mar 25. doi: 10.1002/ccd.27595.
    PubMed     Abstract available


  245. TAKAHASHI M, Badenco N, Monteau J, Gandjbakhch E, et al
    Impact of pacemaker mode in patients with atrioventricular conduction disturbance after trans-catheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Mar 14. doi: 10.1002/ccd.27594.
    PubMed     Abstract available


  246. EITAN A, Witt J, Stripling J, Haselbach T, et al
    Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: Early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli >/=26 mm.
    Catheter Cardiovasc Interv. 2018 Mar 9. doi: 10.1002/ccd.27588.
    PubMed     Abstract available


  247. ABDELGHANI M, de Winter RJ, Miyazaki Y, Modolo R, et al
    Determinants of success and hemodynamic impact of balloon postdilatation of self-expanding transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2018 Mar 9. doi: 10.1002/ccd.27538.
    PubMed     Abstract available


  248. MALCOLMSON JW, Hamshere SM, Joshi A, O'Mahony C, et al
    Doppler echocardiography underestimates the prevalence and magnitude of mid-cavity obstruction in patients with symptomatic hypertrophic cardiomyopathy.
    Catheter Cardiovasc Interv. 2018;91:783-789.
    PubMed     Abstract available


  249. MIZOTE I, Schirmer J, Schafer U
    A case of successful Mitraclip implantation in a patient having a large coaptation gap under extracorporeal membrane oxygenation (ECMO).
    Catheter Cardiovasc Interv. 2018;91:827-830.
    PubMed     Abstract available


    February 2018
  250. SARAF S, Cockburn J, Alsanjari O, Hildick-Smith D, et al
    Transcatheter aortic valve implantation via the superficial femoral artery: An underused access route?
    Catheter Cardiovasc Interv. 2018 Feb 26. doi: 10.1002/ccd.27544.
    PubMed     Abstract available


  251. AZARRAFIY R, Albuquerque FN, Carrillo RG, Cohen MG, et al
    Coil embolization to successfully treat annular rupture during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Feb 22. doi: 10.1002/ccd.27546.
    PubMed     Abstract available


  252. HIOKI H, Watanabe Y, Kozuma K, Yamamoto M, et al
    Risk stratification using lean body mass in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Feb 22. doi: 10.1002/ccd.27547.
    PubMed     Abstract available


  253. BENSON L
    PPVI in children under 20 kilograms: A quid pro quo?
    Catheter Cardiovasc Interv. 2018;91:495-496.
    PubMed     Abstract available


  254. KHAN JM, Rogers T, Schenke WH, Greenbaum AB, et al
    Transcatheter pledget-assisted suture tricuspid annuloplasty (PASTA) to create a double-orifice valve.
    Catheter Cardiovasc Interv. 2018 Feb 6. doi: 10.1002/ccd.27531.
    PubMed     Abstract available


  255. FACCINI A, Butera G
    Tricuspid regurgitation as a complication of Edwards Sapien XT valve implantation in pulmonary position a problem to deal with.
    Catheter Cardiovasc Interv. 2018 Feb 6. doi: 10.1002/ccd.27527.
    PubMed     Abstract available


  256. LIU X, He Y, Zhu Q, Gao F, et al
    Supra-annular structure assessment for self-expanding transcatheter heart valve size selection in patients with bicuspid aortic valve.
    Catheter Cardiovasc Interv. 2018 Feb 5. doi: 10.1002/ccd.27467.
    PubMed     Abstract available


  257. TAKAGI H, Mitta S, Ando T
    Long-term survival after transcatheter versus surgical aortic valve replacement for aortic stenosis: A meta-analysis of observational comparative studies with a propensity-score analysis.
    Catheter Cardiovasc Interv. 2018 Feb 1. doi: 10.1002/ccd.27521.
    PubMed     Abstract available


  258. WITBERG G, Lador A, Yahav D, Kornowski R, et al
    Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta-analysis of randomized trials and propensity score matched observational studies.
    Catheter Cardiovasc Interv. 2018 Feb 1. doi: 10.1002/ccd.27518.
    PubMed     Abstract available


  259. DI MARIO C, Sorini Dini C
    Maximal efficiency is required to minimize complications and hospital stay after TAVR.
    Catheter Cardiovasc Interv. 2018;91:354-355.
    PubMed     Abstract available


  260. SCHNEIDER HE, Gravenhorst V, Paul T, Jacobshagen C, et al
    Insufficiency of a Damus-Kaye-Stansel anastomosis in a Fontan patient: Transfemoral implantation of an Edwards Sapien 3 valve.
    Catheter Cardiovasc Interv. 2018;91:292-295.
    PubMed     Abstract available


    January 2018
  261. SCHAFER U, Kalbacher D, Voigtlander L, Conradi L, et al
    First-in-human implantation of a novel self-expanding supra-annular transcatheter heart valve for transcatheter aortic valve implantation inside a small degenerated aortic surgical bioprosthesis.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27466.
    PubMed     Abstract available


  262. TSURUTA H, Hayashida K, Yashima F, Yanagisawa R, et al
    Incidence, predictors, and midterm clinical outcomes of left ventricular obstruction after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27508.
    PubMed     Abstract available


  263. EL SABBAGH A, Eleid MF, Matsumoto JM, Anavekar NS, et al
    Three-dimensional prototyping for procedural simulation of transcatheter mitral valve replacement in patients with mitral annular calcification.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27488.
    PubMed     Abstract available


  264. KAGASE A, Yamamoto M, Shimura T, Kodama A, et al
    Impact of pre-procedural hyponatremia on clinical outcomes after transcatheter aortic valve replacement: A propensity-matched analysis.
    Catheter Cardiovasc Interv. 2018 Jan 11. doi: 10.1002/ccd.27483.
    PubMed     Abstract available


  265. GARCIA S, Kelly R, Mbai M, Gurevich S, et al
    Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience.
    Catheter Cardiovasc Interv. 2018 Jan 9. doi: 10.1002/ccd.27478.
    PubMed     Abstract available


  266. ALASTI M, Rashid H, Rangasamy K, Kotschet E, et al
    Long-term pacemaker dependency and impact of pacing on mortality following transcatheter aortic valve replacement with the LOTUS valve.
    Catheter Cardiovasc Interv. 2018 Jan 4. doi: 10.1002/ccd.27463.
    PubMed     Abstract available


  267. AMAT-SANTOS IJ, Rojas P, Gutierrez H, Vera S, et al
    Transubclavian approach: A competitive access for transcatheter aortic valve implantation as compared to transfemoral.
    Catheter Cardiovasc Interv. 2018 Jan 3. doi: 10.1002/ccd.27485.
    PubMed     Abstract available


  268. ROGERS T, Lederman RJ
    Percutaneous transaxillary access for TAVR: Another opportunity to stay out of the chest.
    Catheter Cardiovasc Interv. 2018;91:157-158.
    PubMed     Abstract available


  269. AUBERSON D, Gray W
    Good enough...isn't.
    Catheter Cardiovasc Interv. 2018;91:148-149.
    PubMed     Abstract available


  270. GOLESKI PJ, Reisman M, Don CW
    Reversible thrombotic aortic valve restenosis after valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018;91:165-168.
    PubMed     Abstract available


  271. NERLA R, Cremonesi A, Castriota F
    Successful percutaneous paravalvular leak closure followed by transfemoral aortic lotus valve-in-valve implantation in a degenerated surgical bioprosthesis.
    Catheter Cardiovasc Interv. 2018;91:169-174.
    PubMed     Abstract available


    December 2017
  272. GOLDSWEIG AM, Kennedy KF, Kolte D, Abbott JD, et al
    Predictors of patient radiation exposure during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Dec 27. doi: 10.1002/ccd.27452.
    PubMed     Abstract available


  273. HACHINOHE D, Latib A, Agricola E, Colombo A, et al
    Repeat MitraClip for early recurrent mitral regurgitation.
    Catheter Cardiovasc Interv. 2017 Dec 27. doi: 10.1002/ccd.27460.
    PubMed     Abstract available


  274. WANG DD, Eng MH, Greenbaum AB, Myers E, et al
    Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR).
    Catheter Cardiovasc Interv. 2017 Dec 11. doi: 10.1002/ccd.27447.
    PubMed     Abstract available


  275. PATEL JS, Krishnaswamy A, White J, Mick S, et al
    Optimizing hemodynamics of transcatheter aortic valve-in-valve implantation in 19-mm surgical aortic prostheses.
    Catheter Cardiovasc Interv. 2017 Dec 11. doi: 10.1002/ccd.27415.
    PubMed     Abstract available


  276. NAKAJIMA Y, Kar S
    First experience of the usage of a GORE CARDIOFORM Septal Occluder device for treatment of a significant residual commissural mitral regurgitation jet following a MitraClip procedure.
    Catheter Cardiovasc Interv. 2017 Dec 8. doi: 10.1002/ccd.27438.
    PubMed     Abstract available


  277. MILLAN-ITURBE O, Sawaya FJ, Lonborg J, Chow DHF, et al
    Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry.
    Catheter Cardiovasc Interv. 2017 Dec 7. doi: 10.1002/ccd.27440.
    PubMed     Abstract available


  278. RASHID HN, McCormick LM, Talman AH, Ihdayhid AR, et al
    Effect of aorto-ventricular angulation on procedural success in transcatheter aortic valve replacements with the Lotus Valve system.
    Catheter Cardiovasc Interv. 2017 Dec 6. doi: 10.1002/ccd.27378.
    PubMed     Abstract available


  279. SHATILA W, Krajcer Z
    A cardiologist's nightmare: Coronary obstruction during transcatheter aortic valve implantation: How to identify patients at highest risk for this complication.
    Catheter Cardiovasc Interv. 2017;90:1198-1199.
    PubMed     Abstract available


    November 2017
  280. SILASCHI M, Conradi L, Wendler O, Schlingloff F, et al
    The JUPITER registry: One-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27370.
    PubMed     Abstract available


  281. ELEID MF, Reeder GS, Rihal CS
    Comparison of left atrial pressure monitoring with dedicated catheter versus steerable guiding catheter during transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27430.
    PubMed     Abstract available


  282. ALKHALIL A, Golbari S, Song D, Lamba H, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement in end stage renal disease.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27433.
    PubMed     Abstract available


  283. TRENKWALDER T, Pellegrini C, Holzamer A, Philipp A, et al
    Emergency extracorporeal membrane oxygenation in transcatheter aortic valve implantation: A two-center experience of incidence, outcome and temporal trends from 2010 to 2015.
    Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27385.
    PubMed     Abstract available


  284. MAYR NP, Wiesner G, Hapfelmeier A, van der Starre P, et al
    Periprocedural transfusion in patients undergoing transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27382.
    PubMed     Abstract available


  285. SCHOECHLIN S, Brennemann T, Allali A, Ruile P, et al
    Hemodynamic classification of paravalvular leakage after transcatheter aortic valve implantation compared with angiographic or echocardiographic classification for prediction of 1-year mortality.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27384.
    PubMed     Abstract available


  286. FANARI Z, Mahmaljy H, Nandish S, Goswami NJ, et al
    Simultaneous transcatheter transfemoral aortic and transeptal mitral valve replacement using Edward SAPIEN S3.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27410.
    PubMed     Abstract available


  287. ALMEIDA JG, Ferreira SM, Fonseca P, Dias T, et al
    Comparison of self-expanding and balloon-expandable transcatheter aortic valves morphology and association with paravalvular regurgitation: Evaluation using multidetector computed tomography.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27401.
    PubMed     Abstract available


    October 2017
  288. ARORA S, Vaidya SR, Strassle PD, Misenheimer JA, et al
    Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27357.
    PubMed     Abstract available


  289. FLUECKIGER P, Singleton M, Vasu S, Zhao D, et al
    Bioprosthetic tricuspid valve thrombosis: Percutaneous PFO closure to improve hypoxia and respiratory failure.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27217.
    PubMed     Abstract available


  290. TUMMALA R, Banerjee K, Sankaramangalam K, Mick S, et al
    Clinical and procedural outcomes with the SAPIEN 3 versus the SAPIEN XT prosthetic valves in transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27398.
    PubMed     Abstract available


  291. STEINBERG ZL, Morray BH, Jones TK
    Bicaval Medtronic Melody valve implantation for treatment of severe mitral regurgitation following the Mustard repair: A case report.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27373.
    PubMed     Abstract available


  292. DE PALMA R, Ruck A, Settergren M, Saleh N, et al
    Percutaneous axillary arteriotomy closure during transcatheter aortic valve replacement using the MANTA device.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27383.
    PubMed     Abstract available


  293. SHOEIB O, Burzotta F, Aurigemma C, Paraggio L, et al
    Percutaneous transcatheter aortic valve replacement induces femoral artery shrinkage: angiographic evidence and predictors for a new side effect.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27248.
    PubMed     Abstract available


  294. DRAFTS BC, Choi CH, Sangal K, Cammarata MW, et al
    Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27377.
    PubMed     Abstract available


  295. RUPARELIA N, Cao J, Newton JD, Wilson N, et al
    Paravalvular leak closure under intracardiac echocardiographic guidance.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27318.
    PubMed     Abstract available


  296. ANDO T, Akintoye E, Telila T, Briasouolis A, et al
    Hospital outcomes of transcatheter versus surgical aortic valve replacement in female in the United States.
    Catheter Cardiovasc Interv. 2017 Oct 9. doi: 10.1002/ccd.27362.
    PubMed     Abstract available


  297. HTUN WW, Grines C, Schreiber T
    Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic self-expandable bioprosthetic valve.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27346.
    PubMed     Abstract available


  298. CARRERAS ET, Kaneko T, Ramirez-Del Val F, Pelletier MP, et al
    Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27347.
    PubMed     Abstract available


  299. DALL'ARA G, Santarelli A, Marzocchi A, Bacchi Reggiani ML, et al
    Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices.
    Catheter Cardiovasc Interv. 2017 Oct 5. doi: 10.1002/ccd.27328.
    PubMed     Abstract available


  300. FRANKEN M, Lemos PA
    Treating of aortic valve stenosis in real-life: A multifaceted decision-making challenge.
    Catheter Cardiovasc Interv. 2017;90:671-672.
    PubMed     Abstract available


    September 2017
  301. REDDY G, Wang Z, Nishimura RA, Greason KL, et al
    Transcatheter aortic valve replacement for stenotic bicuspid aortic valves: Systematic review and meta analyses of observational studies.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27340.
    PubMed     Abstract available


  302. ANDO T, Briasoulis A, Telila T, Afonso L, et al
    Does mild paravalvular regurgitation post transcatheter aortic valve implantation affect survival? A meta-analysis.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27336.
    PubMed     Abstract available


  303. ALQAHTANI F, Aljohani S, Almustafa A, Alhijji M, et al
    Comparative outcomes of transcatheter aortic valve replacement in African American and Caucasian patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2017 Sep 23. doi: 10.1002/ccd.27257.
    PubMed     Abstract available


  304. DREXEL T, Helmer G, Garcia S, Raveendran G, et al
    Management of left main coronary artery obstruction after transcatheter aortic valve replacement utilizing a periscope approach.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27317.
    PubMed     Abstract available


  305. GIANNINI F, Latib A, Montorfano M, Ruparelia N, et al
    A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27319.
    PubMed     Abstract available


  306. YAHAGI K, Torii S, Ladich E, Kutys R, et al
    Pathology of self-expanding transcatheter aortic valves: Findings from the CoreValve US pivotal trials.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27314.
    PubMed     Abstract available


  307. VAN GILS L, Kroon H, Daemen J, Ren C, et al
    Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27323.
    PubMed     Abstract available


  308. ANDO T, Takagi H, Briasoulis A, Telila T, et al
    A systematic review of reported cases of combined transcatheter aortic and mitral valve interventions.
    Catheter Cardiovasc Interv. 2017 Sep 1. doi: 10.1002/ccd.27256.
    PubMed     Abstract available


    August 2017
  309. DHOBLE A, Bhise V, Nevah MI, Balan P, et al
    Outcomes and readmissions after transcatheter and surgical aortic valve replacement in patients with cirrhosis: A propensity matched analysis.
    Catheter Cardiovasc Interv. 2017 Aug 28. doi: 10.1002/ccd.27232.
    PubMed     Abstract available


  310. HUCZEK Z, Zbronski K, Grodecki K, Scislo P, et al
    Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
    Catheter Cardiovasc Interv. 2017 Aug 26. doi: 10.1002/ccd.27251.
    PubMed     Abstract available


  311. ALKHALIL A, Lamba H, Deo S, Bezerra HG, et al
    Safety of shorter length of hospital stay for patients undergoing minimalist transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 24. doi: 10.1002/ccd.27230.
    PubMed     Abstract available


  312. KRISHNAN S, Daniels D, McCabe JM
    Novel bipolar preshaped left ventricular pacing wire for transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 11. doi: 10.1002/ccd.27244.
    PubMed    


  313. BHARADWAJ AS, Bhatheja S, Sharma SK, Kini AS, et al
    Utility of the guideliner catheter for percutaneous coronary interventions in patients with prior transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 10. doi: 10.1002/ccd.27211.
    PubMed     Abstract available


  314. TELILA T, Akintoye E, Ando T, Merid O, et al
    Hospital teaching status and trascatheter aortic valve replacement outcomes in the United States: Analysis of the national inpatient sample.
    Catheter Cardiovasc Interv. 2017 Aug 10. doi: 10.1002/ccd.27236.
    PubMed     Abstract available


  315. WATERBURY TM, Reeder GS, Pislaru SV, Cabalka AK, et al
    Techniques and outcomes of paravalvular leak repair after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 2. doi: 10.1002/ccd.27224.
    PubMed     Abstract available


  316. KHAN JM, Lederman RJ
    Unnatural milieu: Thrombus after transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2017;90:329-330.
    PubMed     Abstract available


  317. FELDMAN T, Guerrero M
    Balloon aortic valvuloplasty in the TAVR era: Not so new but definitely improved.
    Catheter Cardiovasc Interv. 2017;90:311-312.
    PubMed     Abstract available


    July 2017
  318. VILLABLANCA PA, Mohananey D, Nikolic K, Bangalore S, et al
    Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2017 Jul 24. doi: 10.1002/ccd.27207.
    PubMed     Abstract available


  319. CLAESSEN BE, van den Boogert TPW, Piek JJ
    Recurrent myocardial infarction in a 47-year-old woman with a mechanical mitral valve prosthesis: Atherosclerosis, embolism, or spasm?
    Catheter Cardiovasc Interv. 2017 Jul 12. doi: 10.1002/ccd.27186.
    PubMed     Abstract available


    June 2017
  320. KOEHLE M, Strote JA, Guadagnoli M, Oldemeyer JB, et al
    A novel mechanical mitral valve replacement using Sapien XT.
    Catheter Cardiovasc Interv. 2017 Jun 9. doi: 10.1002/ccd.27149.
    PubMed     Abstract available


  321. YAHAGI K, Ladich E, Kutys R, Mori H, et al
    Pathology of balloon-expandable transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2017 Jun 1. doi: 10.1002/ccd.27160.
    PubMed     Abstract available


  322. EL-SAID HG, Pockett CR, Moore JW
    Percutaneous obliteration of left ventricular cavity to eliminate aortic regurgitation and presumed coronary steal in an infant with hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2017 Jun 1. doi: 10.1002/ccd.27138.
    PubMed     Abstract available


  323. ORVIN K, Kornowski R
    The problem of delirium following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017;89:1292-1293.
    PubMed     Abstract available


  324. KUO JA, Feezel AA, Putnam TN, Schutte DA, et al
    Melody valve implantation within freestyle stentless porcine aortic heterograft.
    Catheter Cardiovasc Interv. 2017;89:1224-1230.
    PubMed     Abstract available


    May 2017
  325. GUERRERO M, Salinger M, Pursnani A, Pearson P, et al
    Transseptal transcatheter mitral valve-in-valve: A step by step guide from preprocedural planning to postprocedural care.
    Catheter Cardiovasc Interv. 2017 May 30. doi: 10.1002/ccd.27128.
    PubMed     Abstract available


  326. DOERNER J, Kupczyk PA, Wilsing M, Luetkens JA, et al
    Cerebral white matter lesion burden is associated with the degree of aortic valve calcification and predicts peri-procedural cerebrovascular events in patients undergoing transcatheter aortic valve implantation (TAVI).
    Catheter Cardiovasc Interv. 2017 May 26. doi: 10.1002/ccd.27122.
    PubMed     Abstract available


  327. HO EC, Ahmed N, Connelly KA, Fam NP, et al
    Transcatheter edge-to-edge repair of anterior mitral flail through a dehisced annuloplasty ring.
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27126.
    PubMed     Abstract available


  328. WITBERG G, Finkelstein A, Barbash I, Assali A, et al
    Prognostic significance of aortic valve gradient in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27124.
    PubMed     Abstract available


  329. TARAMASSO M, Denegri A, Kuwata S, Rickli H, et al
    Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience.
    Catheter Cardiovasc Interv. 2017 May 13. doi: 10.1002/ccd.27100.
    PubMed     Abstract available


  330. LINKE A, Chandrasekhar J, Sartori S, Lefevre T, et al
    Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in Transcatheter Aortic Valve Replacement: Results From The BRAVO 3 Randomized Trial.
    Catheter Cardiovasc Interv. 2017 May 12. doi: 10.1002/ccd.27154.
    PubMed     Abstract available


  331. HENGSTENBERG C, Chandrasekhar J, Sartori S, Lefevre T, et al
    Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following Transcatheter Aortic Valve Replacement: Results From The BRAVO 3 Randomized Trial.
    Catheter Cardiovasc Interv. 2017 May 11. doi: 10.1002/ccd.27155.
    PubMed     Abstract available


  332. GEORGE B, Voelkel A, Kotter J, Leventhal A, et al
    A novel approach to percutaneous removal of large tricuspid valve vegetations using suction filtration and veno-venous bypass: A single center experience.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27097.
    PubMed     Abstract available


  333. CONDADO JF, Corrigan FE 3rd, Lerakis S, Parastatidis I, et al
    Anatomical risk models for paravalvular leak and landing zone complications for balloon-expandable transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.26987.
    PubMed     Abstract available


  334. BRUNNER NW, Yue SF, Stub D, Ye J, et al
    The prognostic importance of the diastolic pulmonary gradient, transpulmonary gradient, and pulmonary vascular resistance in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27107.
    PubMed     Abstract available


  335. GREENBAUM AB, Condado JF, Eng M, Lerakis S, et al
    Long or redundant leaflet complicating transcatheter mitral valve replacement: Case vignettes that advocate for removal or reduction of the anterior mitral leaflet.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27054.
    PubMed     Abstract available


  336. SALNA M, Khalique OK, Chiuzan C, Kurlansky P, et al
    Impact of small prosthesis size on transcatheter or surgical aortic valve replacement outcomes.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27120.
    PubMed     Abstract available


  337. OKOH AK, Chauhan D, Kang N, Haik N, et al
    The impact of frailty status on clinical and functional outcomes after transcatheter aortic valve replacement in nonagenarians with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2017 May 2. doi: 10.1002/ccd.27083.
    PubMed     Abstract available


  338. ALRAIES MC, Satler LF
    End-stage renal disease and severe aortic stenosis. Does valve replacement improve one-year outcomes?
    Catheter Cardiovasc Interv. 2017;89:1116-1117.
    PubMed    


    April 2017
  339. HERRMANN HC, Szeto WY, Litt H, Vernick W, et al
    Novel use of perfusion balloon inflation to avoid outflow tract obstruction during transcatheter mitral valve-in-valve replacement.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.27068.
    PubMed     Abstract available


  340. AUFFRET V, Regueiro A, Campelo-Parada F, Del Trigo M, et al
    Feasibility, safety, and efficacy of transcatheter aortic valve replacement without balloon predilation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 Apr 12. doi: 10.1002/ccd.27040.
    PubMed     Abstract available


  341. SARDAR P, Kundu A, Chatterjee S, Feldman DN, et al
    Transcatheter versus surgical aortic valve replacement in intermediate-risk patients: Evidence from a meta-analysis.
    Catheter Cardiovasc Interv. 2017 Apr 11. doi: 10.1002/ccd.27041.
    PubMed     Abstract available


  342. RUIZ CE, Chi-Hion L, Vladimir J, Gila P, et al
    Hopscotch technique: A novel method for percutaneous closure of paravalvular leaks.
    Catheter Cardiovasc Interv. 2017;89:944-950.
    PubMed     Abstract available


    March 2017
  343. YOUNG MN, Elmariah S, Kennedy KF, Inglessis I, et al
    Utilization and outcomes of transcatheter aortic valve replacement in the United States shortly after device approval.
    Catheter Cardiovasc Interv. 2017 Mar 22. doi: 10.1002/ccd.27018.
    PubMed     Abstract available


  344. TANG GH, Cohen M, Dutta T, Undemir C, et al
    Afterload mismatch after transcatheter mitral valve repair with MitraClip for degenerative mitral regurgitation in acute cardiogenic shock.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.27019.
    PubMed     Abstract available


  345. MOHAMMAD NIJRES B, Kenny D, Kazmouz S, Hijazi ZM, et al
    Transcatheter closure of unroofed coronary sinus using covered stents in an adult with drainage of the coronary sinus to the right ventricle after supra-annular tricuspid valve replacement.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26996.
    PubMed     Abstract available


  346. KHERADA N, Brenes JC, Kini AS, Dangas GD, et al
    Assessment of trans-aortic pressure gradient using a coronary pressure wire in patients with mechanical aortic and mitral valve prostheses.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26962.
    PubMed     Abstract available


  347. DEUSCHL F, Schofer N, Seiffert M, Hakmi S, et al
    Direct percutaneous transaxillary implantation of a novel self-expandable transcatheter heart valve for aortic stenosis.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26986.
    PubMed     Abstract available


  348. KOIFMAN E, Patel N, Weissman G, Kiramijyan S, et al
    Outcome of implantation of a second self-expanding valve for the treatment of residual significant aortic regurgitation.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26960.
    PubMed     Abstract available


  349. SUMMERS MR, Mick S, Kapadia SR, Krishnaswamy A, et al
    Emergency valve-in-valve transcatheter aortic valve replacement in a patient with degenerated bioprosthetic aortic stenosis and cardiogenic shock on veno-arterial extracorporeal membrane oxygenation.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26990.
    PubMed     Abstract available


  350. AL'AREF SJ, Devereux RB, Cheung JW, Bergman G, et al
    Bioprosthetic mitral valve paravalvular leak closure using intracardiac echocardiography-guided three dimensional electroanatomic mapping.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26958.
    PubMed     Abstract available


  351. ARAI T, Lefevre T, Hovasse T, Garot P, et al
    Incidence and predictors of coronary obstruction following transcatheter aortic valve implantation in the real world.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26982.
    PubMed     Abstract available


  352. MEDURI C, Kauten J, Vannan M, Rajagopal V, et al
    First report of a simultaneous transcatheter mitral valve-in-valve and aortic valve replacement in a left ventricular assist device patient.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26983.
    PubMed     Abstract available


  353. GUERRERO M, Wang DD, Himbert D, Urena M, et al
    Short-term results of alcohol septal ablation as a bail-out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification.
    Catheter Cardiovasc Interv. 2017 Mar 7. doi: 10.1002/ccd.26975.
    PubMed     Abstract available


  354. VEJPONGSA P, Bhise V, Charitakis K, Vernon Anderson H, et al
    Early readmissions after transcatheter and surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Mar 2. doi: 10.1002/ccd.26945.
    PubMed     Abstract available


  355. LIAO YB, Zhao ZG, Wei X, Xu YN, et al
    Transcatheter aortic valve implantation with the self-expandable venus A-Valve and CoreValve devices: Preliminary Experiences in China.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Abstract available


  356. CAIXETA A, Lemos PA
    Transcatheter aortic valve replacement by a minimalist approach: A breath of fresh air for patients with chronic obstructive pulmonary disease.
    Catheter Cardiovasc Interv. 2017;89:781-782.
    PubMed    


  357. HEIN-ROTHWEILER R, Jochheim D, Rizas K, Egger A, et al
    Aortic annulus to left coronary distance as a predictor for persistent left bundle branch block after TAVI.
    Catheter Cardiovasc Interv. 2017;89:E162-E168.
    PubMed     Abstract available


  358. STEINVIL A, Satler L
    Does the removal of the temporary pacer wire for BAV and TAVR really simplify the procedure?
    Catheter Cardiovasc Interv. 2017;89:787-788.
    PubMed    


    February 2017
  359. CONDADO JF, Maini A, Leshnower B, Thourani V, et al
    End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes?
    Catheter Cardiovasc Interv. 2017 Feb 17. doi: 10.1002/ccd.26875.
    PubMed     Abstract available


  360. JAMES RODRIGUEZ R, Prasad A
    Transcatheter aortic valve replacement and renal function: A complex relationship.
    Catheter Cardiovasc Interv. 2017;89:460-461.
    PubMed    


  361. CONDADO JF, Block PC
    Gender inequalities in transcatheter aortic valve replacement: The jury is still out.
    Catheter Cardiovasc Interv. 2017;89:436-437.
    PubMed    


  362. COOLS B, Rega F, Gewillig M
    Transhepatic implant of a trimmed Melody valved stent in tricuspid position in a 1-year-old infant.
    Catheter Cardiovasc Interv. 2017;89:E84-E89.
    PubMed     Abstract available


  363. PELBERG J, Gray WA
    Good to great: TAVR tackles stroke risk.
    Catheter Cardiovasc Interv. 2017;89:478-479.
    PubMed    


  364. YADAV PK, Gilchrist IC
    Significant leak after TAVR: A plug is an option.
    Catheter Cardiovasc Interv. 2017;89:468-469.
    PubMed    


  365. RAKITA V, Lakhter V, Patil P, O'Neill BP, et al
    Intermediate term hemodynamic effects of single inferior vena cava valve implant for the treatment of severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2017 Feb 7. doi: 10.1002/ccd.26931.
    PubMed     Abstract available


  366. SORAJJA P, Kanda B, Bae R, Pedersen WA, et al
    Maneuvers for technical success with transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26899.
    PubMed     Abstract available


  367. CZARNECKI A, Qiu F, Koh M, Prasad TJ, et al
    Clinical outcomes after trans-catheter aortic valve replacement in men and women in Ontario, Canada.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26906.
    PubMed     Abstract available


  368. MONTONE RA, Testa L, Fraccaro C, Montorfano M, et al
    Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26914.
    PubMed     Abstract available


  369. SHAH AH, Horlick EM, Eicken A, Asnes JD, et al
    Transcatheter valve implantation for right atrium-to-right ventricle conduit obstruction or regurgitation after modified Bjork-fontan procedure.
    Catheter Cardiovasc Interv. 2017;89:298-305.
    PubMed     Abstract available


  370. HAGLER DJ
    The Lababidi Procedure: Is Neonatal Balloon Aortic Valvotomy Worth the Risk?
    Catheter Cardiovasc Interv. 2017;89:296-297.
    PubMed    


    January 2017
  371. HORN P, Hellhammer K, Minier M, Stenzel MA, et al
    Deep sedation Vs. general anesthesia in 232 patients undergoing percutaneous mitral valve repair using the MitraClip(R) system.
    Catheter Cardiovasc Interv. 2017 Jan 23. doi: 10.1002/ccd.26884.
    PubMed     Abstract available


  372. ABDELGHANI M, Tateishi H, Miyazaki Y, Cavalcante R, et al
    Angiographic assessment of aortic regurgitation by video-densitometry in the setting of TAVI: Echocardiographic and clinical correlates.
    Catheter Cardiovasc Interv. 2017 Jan 21. doi: 10.1002/ccd.26926.
    PubMed     Abstract available


  373. MCCABE JM, Dean LS
    Pass the Rock: calcium, the achilles heel of transcatheter valve replacement.
    Catheter Cardiovasc Interv. 2017;89:142-143.
    PubMed     Abstract available


    December 2016
  374. JATENE T, Castro-Filho A, Meneguz-Moreno RA, Siqueira DA, et al
    Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2016 Dec 28. doi: 10.1002/ccd.26837.
    PubMed     Abstract available


  375. RASMUSSEN VG, Kanstrup HL, Nielsen-Kudsk JE
    Percutaneous balloon valvuloplasty in carcinoid pulmonary valve stenosis.
    Catheter Cardiovasc Interv. 2016;88:1174-1176.
    PubMed     Abstract available


  376. MILLAN X, Azzalini L, Khan R, Cournoyer D, et al
    Efficacy of a balloon-expandable vascular access system in transfemoral TAVI patients.
    Catheter Cardiovasc Interv. 2016;88:1145-1152.
    PubMed     Abstract available


  377. CILINGIROGLU M, Marmagkiolis K
    Invasive Hemodynamic Assessment During Mitra-Clip Implantation: Should It Be the New Standard?
    Catheter Cardiovasc Interv. 2016;88:1143-1144.
    PubMed     Abstract available


    November 2016
  378. FETTERLY K, Greason K, Mathew V
    Balloon Valvuloplasty to Predict X-ray Projection Angles that are Perpendicular to Cardiovascular Structures: A TAVI Patient Feasibility Study.
    Catheter Cardiovasc Interv. 2016 Nov 29. doi: 10.1002/ccd.26879.
    PubMed     Abstract available


  379. MASSUMI M, Krajcer Z
    To BAV or not to BAV, that is a TAVR question.
    Catheter Cardiovasc Interv. 2016;88:986-987.
    PubMed    


  380. YADAV PK, Eng MH
    A toast to no sternotomy.
    Catheter Cardiovasc Interv. 2016;88:960-961.
    PubMed    


  381. GUERRERO I, Dhoble A, Fasulo M, Denktas AE, et al
    Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Catheter Cardiovasc Interv. 2016;88:971-977.
    PubMed     Abstract available


  382. FAURIE B, Abdellaoui M, Wautot F, Staat P, et al
    Rapid pacing using the left ventricular guidewire: Reviving an old technique to simplify BAV and TAVI procedures.
    Catheter Cardiovasc Interv. 2016;88:988-993.
    PubMed     Abstract available


  383. RUPARELIA N, Mangieri A, Ancona M, Giannini F, et al
    Percutaneous Transcatheter Treatment for Tricuspid Bioprosthesis Failure.
    Catheter Cardiovasc Interv. 2016;88:994-1001.
    PubMed     Abstract available


  384. FORTUNATO DE CANO S, Nicolas Cano M, de Ribamar Costa J Jr, Alves Pinheiro J Jr, et al
    Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy.
    Catheter Cardiovasc Interv. 2016;88:953-960.
    PubMed     Abstract available


  385. CORRIGAN FE 3RD, Douglas JS Jr
    Now you see me, now you don't: The case of a vanishing outflow gradient in a patient with hypertrophic cardiomyopathy.
    Catheter Cardiovasc Interv. 2016;88:1006-1009.
    PubMed     Abstract available


  386. PRASAD M, Geske JB, Sorajja P, Ommen SR, et al
    Hemodynamic changes in systolic and diastolic function during isoproterenol challenge predicts symptomatic response to myectomy in hypertrophic cardiomyopathy with labile obstruction.
    Catheter Cardiovasc Interv. 2016;88:962-970.
    PubMed     Abstract available


  387. LIEBREGTS M, Vriesendorp PA, Steggerda RC, Schinkel AF, et al
    Effect of alcohol dosage on long-term outcomes after alcohol septal ablation in patients with hypertrophic cardiomyopathy.
    Catheter Cardiovasc Interv. 2016;88:945-952.
    PubMed     Abstract available


  388. KAWASE Y, Matsuo H
    A modified method (MK method) of alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopahty.
    Catheter Cardiovasc Interv. 2016;88:1002-1005.
    PubMed     Abstract available


  389. CONDADO JF, Haider MN, Lerakis S, Keegan P, et al
    Does minimalist transfemoral transcatheter aortic valve replacement produce better survival in patients with severe chronic obstructive pulmonary disease?
    Catheter Cardiovasc Interv. 2016 Nov 12. doi: 10.1002/ccd.26683.
    PubMed     Abstract available


  390. ZAMAN S, McCormick L, Gooley R, Rashid H, et al
    Incidence and predictors of permanent pacemaker implantation following treatment with the repositionable Lotus transcatheter aortic valve.
    Catheter Cardiovasc Interv. 2016 Nov 12. doi: 10.1002/ccd.26857.
    PubMed     Abstract available


  391. CONROTTO F, D'Ascenzo F, D'Amico M, Moretti C, et al
    Outcomes of patients with low-pressure aortic gradient undergoing transcatheter aortic valve implantation: A Meta-analysis.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26839.
    PubMed     Abstract available


  392. PICARD F, Tadros VX, Asgar AW
    From tricuspid to double orifice Morphology: Percutaneous tricuspid regurgitation repair with the MitraClip device in congenitally corrected-transposition of great arteries.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26834.
    PubMed     Abstract available


  393. MCELHINNEY DB
    Hybrid transcatheter pulmonary valve replacement: Moving into the mainstream?
    Catheter Cardiovasc Interv. 2016;88:811-813.
    PubMed    


  394. SOSNOWSKI C, Matella T, Fogg L, Ilbawi M, et al
    Hybrid pulmonary artery plication followed by transcatheter pulmonary valve replacement: Comparison with surgical PVR.
    Catheter Cardiovasc Interv. 2016;88:804-810.
    PubMed     Abstract available


  395. LINDSAY I, Aboulhosn J, Salem M, Levi D, et al
    Aortic root compression during transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2016;88:814-821.
    PubMed     Abstract available


  396. PATIL NC, Saxena A, Gupta SK, Juneja R, et al
    Perforating the atretic pulmonary valve with CTO hardware: Technical aspects.
    Catheter Cardiovasc Interv. 2016;88:E145-E150.
    PubMed     Abstract available


  397. CHAKRABORTY S, Vadivelu R, Bagga S
    Percutaneous balloon mitral valvuloplasty under neuroprotection: Too Early for Knighthood.
    Catheter Cardiovasc Interv. 2016;88:E151-E154.
    PubMed     Abstract available


    October 2016
  398. KODAMA A, Yamamoto M, Shimura T, Kagase A, et al
    Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
    Catheter Cardiovasc Interv. 2016 Oct 27. doi: 10.1002/ccd.26686.
    PubMed     Abstract available


  399. KISCHE S, D'Ancona G, Agma HU, El-Achkar G, et al
    Trans-catheter aortic valve implantation with the direct flow medical prosthesis: Single center short-term clinical and echocardiographic outcomes.
    Catheter Cardiovasc Interv. 2016 Oct 14. doi: 10.1002/ccd.26528.
    PubMed     Abstract available


  400. D'ANCONA G, Agma HU, Ince H, El-Achkar G, et al
    Transcatheter aortic valve implantation with the direct flow medical prosthesis: Impact of native aortic valve calcification degree on outcomes.
    Catheter Cardiovasc Interv. 2016 Oct 14. doi: 10.1002/ccd.26517.
    PubMed     Abstract available


  401. HILLING-SMITH R, Cockburn J, Dooley M, Parker J, et al
    Rapid pacing using the 0.035-in. Retrograde left ventricular support wire in 208 cases of transcatheter aortic valve implantation and balloon aortic valvuloplasty.
    Catheter Cardiovasc Interv. 2016 Oct 11. doi: 10.1002/ccd.26720.
    PubMed     Abstract available


  402. LOYALKA P, Nascimbene A, Schechter M, Petrovic M, et al
    Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2016 Oct 3. doi: 10.1002/ccd.26723.
    PubMed     Abstract available


  403. LANDES U, Sagie A, Kornowski R
    Transcatheter aortic valve implantation in degenerative sutureless perceval aortic bioprosthesis.
    Catheter Cardiovasc Interv. 2016 Oct 3. doi: 10.1002/ccd.26576.
    PubMed     Abstract available


  404. SCHNEIDER AE, Delaney JW, Cabalka AK
    Non-infectious thrombosis of the melody(R) valve: A tale of two cities.
    Catheter Cardiovasc Interv. 2016;88:600-604.
    PubMed     Abstract available


  405. YILDIRIM A, Goktekin O, Gorgulu S, Norgaz T, et al
    A New Specific Device in Transcatheter Prosthetic Paravalvular Leak Closure: A Prospective Two-Center Trial.
    Catheter Cardiovasc Interv. 2016;88:618-624.
    PubMed     Abstract available


  406. DAVIDSON LJ, Davidson CJ
    Stroke Prevention: Let's Prepare for Generation X TAVR.
    Catheter Cardiovasc Interv. 2016;88:653-655.
    PubMed     Abstract available


    September 2016
  407. ACHARJI S, Agnihotri A, Carrozza J
    Transcatheter aortic valve replacement in unicuspid aortic valve stenosis (CCI-16-0461).
    Catheter Cardiovasc Interv. 2016 Sep 23. doi: 10.1002/ccd.26798.
    PubMed     Abstract available


  408. HARPER AR, Dawkins S, Newton JD
    Late subannular aortic root rupture following transcatheter aortic valve implantation presenting as ST elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26724.
    PubMed     Abstract available


  409. SULLIVAN PM, Rubio AE, Johnston TA, Jones TK, et al
    Long-term outcomes and re-interventions following balloon aortic valvuloplasty in pediatric patients with congenital aortic stenosis: A single-center study.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26722.
    PubMed     Abstract available


  410. HAMM K, Zacher M, Hautmann M, Gietzen F, et al
    Influence of experience on procedure steps, safety, and functional results in edge to edge mitral valve repair-a single center study.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26806.
    PubMed     Abstract available


  411. OKUYAMA K, Chakravarty T, Makkar RR
    Percutaneous transapical pseudoaneurysm closure following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Sep 13. doi: 10.1002/ccd.26494.
    PubMed     Abstract available



  412. Aortic Regurgitation Following Transcatheter Aortic Valve Replacement: Impact of Preprocedural Left Ventricular Diastolic Filling Patterns on Late Clinical Outcomes. DOI: 10.1002/ccd.26298.
    Catheter Cardiovasc Interv. 2016;88:500.
    PubMed    


  413. BROWN SC, Cools B, Gewillig M
    Cracking a tricuspid perimount bioprosthesis to optimize a second transcatheter sapien valve-in-valve placement.
    Catheter Cardiovasc Interv. 2016;88:456-9.
    PubMed     Abstract available


  414. FELDMAN T, Pearson P, Smart SS
    Percutaneous closure of post TAVR LV apical pseudoaneurysm.
    Catheter Cardiovasc Interv. 2016;88:479-85.
    PubMed     Abstract available


  415. KORNOWSKI R
    The 3 S's of the Sapien balloon expandable valve.
    Catheter Cardiovasc Interv. 2016;88:476-8.
    PubMed     Abstract available


    August 2016
  416. JIVANJI SG, Derrick G, Khambadkone S
    Doubly committed subarterial ventricular septal defect: A risk factor for aortic distortion in patients considered for percutaneous pulmonary valve implantation?
    Catheter Cardiovasc Interv. 2016;88:244-7.
    PubMed     Abstract available


  417. SPITZER SG, Wilbring M, Alexiou K, Stumpf J, et al
    Surgical cut-down or percutaneous access-which is best for less vascular access complications in transfemoral TAVI?
    Catheter Cardiovasc Interv. 2016;88:E52-8.
    PubMed     Abstract available


  418. CAMMALLERI V, Romeo F, Ussia GP
    Hemodynamic complications during transcatheter MitraClip repair in presence of congenital atrial septal defect.
    Catheter Cardiovasc Interv. 2016;88:307-11.
    PubMed     Abstract available


  419. SAFIAN RD, Hanzel G
    Management of vascular access after TAVR: Let's keep it simple.
    Catheter Cardiovasc Interv. 2016;88:285-6.
    PubMed     Abstract available


    July 2016
  420. ABU SALEH WK, Tang GH, Ahmad H, Cohen M, et al
    Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis.
    Catheter Cardiovasc Interv. 2016;88:135-43.
    PubMed     Abstract available


  421. SEGUELA PE, Roubertie F, Thambo JB
    Distortion of the left anterior descending coronary artery after pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2016;88:99-102.
    PubMed     Abstract available


  422. SINGH K, Qutub M, Carson K, Hibbert B, et al
    A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy.
    Catheter Cardiovasc Interv. 2016;88:107-15.
    PubMed     Abstract available


  423. FRISOLI TM, Guerrero M, O'Neill WW
    Mechanical circulatory support with impella to facilitate percutaneous coronary intervention for post-TAVI bilateral coronary obstruction.
    Catheter Cardiovasc Interv. 2016;88:E34-7.
    PubMed     Abstract available


  424. YADAV PK, Eng MH
    Size does matter but is there an obesity paradox in TAVR?
    Catheter Cardiovasc Interv. 2016;88:125-6.
    PubMed     Abstract available


  425. BADER Y, Kimmelstiel C
    Ablation or surgery for medically refractory HCM. Updating an imperfect dataset.
    Catheter Cardiovasc Interv. 2016;88:116-7.
    PubMed     Abstract available


    June 2016
  426. GILCHRIST IC, Hansen J
    Between a rock and a hard place: TAVR and ESRD.
    Catheter Cardiovasc Interv. 2016;87:1322-3.
    PubMed     Abstract available


    April 2016
  427. INOHARA T, Hayashida K, Watanabe Y, Yamamoto M, et al
    Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries.
    Catheter Cardiovasc Interv. 2016;87:963-70.
    PubMed     Abstract available


  428. FUJITA B, Scholtz S, Ensminger S
    Valve-in-valve using an Edwards Sapien XT into a JenaValve in a patient with a low originating left coronary artery and a heavily calcified aorta.
    Catheter Cardiovasc Interv. 2016;87:989-92.
    PubMed     Abstract available


    March 2016
  429. BOE BA, Bocks ML, Armstrong AK
    Contained rupture of patched right ventricular outflow tracts during balloon sizing for percutaneous pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2016;87:768-72.
    PubMed     Abstract available


  430. ELEID MF, Asirvatham SJ, Cabalka AK, Hagler DJ, et al
    Transcatheter tricuspid valve-in-valve in patients with transvalvular device leads.
    Catheter Cardiovasc Interv. 2016;87:E160-5.
    PubMed     Abstract available


    February 2016
  431. PHILLIPS AB, Nevin P, Shah A, Olshove V, et al
    Development of a novel hybrid strategy for transcatheter pulmonary valve placement in patients following transannular patch repair of tetralogy of fallot.
    Catheter Cardiovasc Interv. 2016;87:403-10.
    PubMed     Abstract available


  432. MULLER B, Ghawi H, Heitschmidt MG, Fogg L, et al
    Medium-term CT evaluation of stent geometry, integrity, and valve function of the Edwards SAPIEN transcatheter heart valve in the pulmonary position.
    Catheter Cardiovasc Interv. 2016;87:E97-103.
    PubMed     Abstract available


  433. SMOLKA G, Pysz P, Jasinski M, Roleder T, et al
    Multiplug paravalvular leak closure using Amplatzer Vascular Plugs III: A prospective registry.
    Catheter Cardiovasc Interv. 2016;87:478-87.
    PubMed     Abstract available


    January 2016
  434. TOMMASO CL
    Learning curves for TAVR: Not quite see one, do one teach one.
    Catheter Cardiovasc Interv. 2016;87:163-4.
    PubMed     Abstract available


  435. CILINGIROGLU M, Marmagkiolis K
    A glimpse into the future of TAVR.
    Catheter Cardiovasc Interv. 2016;87:152-3.
    PubMed     Abstract available


  436. HOLZER RJ, Hijazi ZM
    Transcatheter pulmonary valve replacement: State of the art.
    Catheter Cardiovasc Interv. 2016;87:117-28.
    PubMed     Abstract available


  437. NOAD RL, Johnston N, McKinley A, Dougherty M, et al
    A pathway to earlier discharge following TAVI: Assessment of safety and resource utilization.
    Catheter Cardiovasc Interv. 2016;87:134-42.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: